Chemical,letrozole
Chemical,TAM
Chemical,alendronate
Chemical,GEM
Chemical,MTT
Chemical,tamoxifen
Chemical,silicaGel
Disease,seromaAspirations
Disease,metastaticBreastCancer
Disease,breastCancers
Disease,polyploid
Disease,death
Disease,cancer
Disease,ESCC
Disease,breastCancerDiagnosis
Disease,cognitiveDecline
Disease,early-stageBreastCancer
Disease,TNBC
Disease,breastCancer
Disease,residualDisease
Disease,toxicity
Disease,advancedBreastCancer
Disease,headache
Gene,RANKL
Gene,hormoneReceptor
Gene,SOX4
Gene,lincRNA-ROR
Other,causeOfDeath
cancer,importantGrowthPathwayInHrPositiveBreastCancer
Other,paper
Other,immunohistochemistry
cancer,cyclin-dependentKinasesApprovedForTreatmentOfReceptor-positiveHumanEpidermalGrowthFactorReceptorBreastCancerInCombination
Other,kinasesApprovedForTreatmentInCombinationWithFulvestrant
Other,distances
Other,maintained
cancer,kinasesApprovedForTreatmentOfHumanEpidermalGrowthFactorReceptor2-negativeAdvancedBreastCancer
Other,withDevelopmentOfHigh-throughputSequencingHaveDiscoveredInTumorousTissues
cancer,kinasesApprovedForTreatmentOfReceptor-positiveGrowthFactorReceptor2-negativeAdvancedBreastCancer
Other,threeVisualRepresentations
Other,expectedEnhancementOfTissuesConsistentWithGivenInputParameters
Other,4dDigitalBreastPhantom
cancer,combinationTherapyForPatientsWithBreastCancerDueToToxicities
cancer,effectsOfTamoxifenOnErCancer
Other,lateRecurrencesInPatients
Other,fewPeptidesDerivedAsVaccineDeliveryModalitiesForTreatment
Other,tissueSectionsFollowedByComputationalApproach
Other,threeMicroarrayDatasets
Other,estrogen-responsiveGenes
cancer,kinasesApprovedForTreatmentOfHormoneReceptor-positiveHumanEpidermalGrowthFactorReceptorAdvancedBreastCancerInCombination
Other,ER-driven
Other,recurrence
Other,proliferationOwing
Other,recurrencesInPatientsWithTumors
cancer,clinicalOutcomeOfHr-positiveBreastCancerPatientsTreatedWithPalbociclib
Other,inhibitor
Other,symptomsAssociatedWithEarlySurgicalMenopause
Other,aspectsOfMalignantPhenotypeIncludingCellProliferation
irradiation,associationOfChemotherapyWithBoost
Other,rateOfComplications
Other,aldehydeDehydrogenase
Other,oralAgentForTreatment
Other,resultsOfStudies
Other,willAllocatedToOneThreeTreatmentArmsConsistingOfFlapFixation
cancer,combinationTherapyForPatientsWithAdvancedRecurrentBreastCancerDueToToxicities
Other,hasLinkedWithTumorSurvival
Other,canDeliveredByPractice-basedTeamWithinSemi-structuredPatientEducationAppointment
Other,systemMetastasesAmongSevereMalignancies
cancer,cyclin-dependentKinasesApprovedForTreatmentOfReceptor-positiveGrowthFactorReceptorBreastCancerInCombination
Other,karyotype
Other,treatmentFailure
Other,westernBlotAssay
Other,wholeBreast
cancer,developmentOfGenerationOfTargetedTherapiesForAdvancedBreastCancer
Other,635Percecnt
cancer,growthPathwayInHrPositiveBreastCancer
Other,nabRegimen
cancer,kinasesApprovedForTreatmentOfHormoneReceptor-positiveGrowthFactorReceptorBreastCancerInCombination
Other,single-center
Other,impactOfHeterogeneityForTreatmentSelection
Other,4226Â±856Years
Other,quantitativePcr
Other,tnbcCells
perfusion,4dBreastPhantomIncludingContrastEnhancementForSimulationOfDedicatedBreastCtPerfusionImaging
Other,symptoms
Other,g2In97Percecnt
Other,patient-based4dBreastPhantomIncludingTime-varyingContrastEnhancementForSimulation
Other,cellApoptosis
Other,inPhageDisplayImmunotherapyPresentedByGeneticFusionsToPhageCoatProteins
Other,medicalFiles
Other,them
Other,inMultivariableCox'sHazardsSurvivalModelAssociatedWithHazardRatioForBoneMetastasis
multicatheter,multicatheterHigh-dose-rateBrachytherapy
Other,addition
Other,roleOfIrAntagonistS961OnIrSignallingInMcf-7
Other,realisticPatient-based4dBreastPhantomIncludingTime-varyingContrastEnhancement
Other,antibody
cancer,cyclin-dependentKinasesApprovedForTreatmentOfReceptor-positiveGrowthFactorReceptor2-negativeAdvancedBreastCancerInCombination
Other,laboratoryAsTherapeutics
Other,aspectsOfTheirLife
Other,found
Other,developmentOfGenerationOfTherapies
Other,patient-based4dBreastPhantomIncludingContrastEnhancement
Other,associated
Other,twoGroups
Other,driversOfProliferation
Other,realisticPatient-based4dBreastPhantomIncludingContrastEnhancement
cancer,cyclin-dependentKinasesApprovedForTreatmentOfHormoneReceptor-positiveHumanEpidermalGrowthFactorReceptorBreastCancerInCombination
Other,biopsiedLungTissue
Other,mayFactorInProgression
Other,phenotype
Other,methods
Other,breastTherapy
cancer,kinasesApprovedForTreatmentOfHormoneReceptor-positiveHumanEpidermalGrowthFactorReceptor2-negativeAdvancedBreastCancer
cancer,combinationTherapyForPatientsWithAdvancedBreastCancerDue
cancer,post-menopausalWomenWithEarlyBreastCancer
perfusion,patient-based4dDigitalBreastPhantomIncludingContrastEnhancementForSimulationOfBreastCtPerfusionImaging
Other,characteristics
Other,healthyPatient
Other,treatment
Other,developmentOfGenerationOfTargetedTherapies
Other,searchOfDataOnPalbociclibInAscoProceedings
Other,14Mg/m2ForEri
Other,highDegreeOfConnectivity
Other,degree
cancer,kinasesApprovedForTreatmentOfHormoneReceptor-positiveGrowthFactorReceptor2-negativeAdvancedBreastCancerInCombination
perfusion,perfusionInTypesOfBreastLesions
Other,canDelivered
Other,utilization
Other,timeToTreatmentFailureOfPalbociclibAsSecond-lineOfTherapy
cancer,kinasesApprovedForTreatmentOfGrowthFactorReceptorBreastCancerInCombination
Other,patient-based4dDigitalBreastPhantomIncludingContrastEnhancement
Other,searchOfDataInFdaWebsiteInAscoProceedings
Other,potentialRelationshipBetweenSexualDysfunction
Other,associationWithBoost
Other,numberConsistOfNumberOfPatientClinicVisits
Other,expressedGenesBetweenTnbc
Other,diseaseProgressionFollowingEndocrineTherapy
brachytherapy,interstitialBrachytherapy
Other,cancer-relatedDeath
cancer,motilityPotentialOfBreastCancerCells
cancer,cyclin-dependentKinasesApprovedForTreatmentOfReceptor-positiveGrowthFactorReceptor2-negativeBreastCancerInCombination
Other,treatableDisease
Other,dimensionsOf
cancer,cyclin-dependentKinasesApprovedForTreatmentOfGrowthFactorReceptor2-negativeBreastCancerInCombination
cancer,mostFrequentlyOccurringCancer
Other,low
Other,6SubtypesWithSignatures
Other,womenWithHer2-positiveBcsTreatedWithTrastuzumab
Other,canDeliveredEffectivelyByPractice-basedClinicalTeam
Other,goal-setting
Other,presentlyLaboratoryAsOncolyticTherapeutics
cancer,cyclin-dependentKinasesApprovedForTreatmentOfHormoneReceptor-positiveGrowthFactorReceptorBreastCancerInCombination
Other,anticipated
Other,managementChallengesInTreatment
Other,NSM
perfusion,perfusionParametersAssociatedWithTissueVoxel
Other,canDeliveredByPractice-basedClinicalTeam
cancer,cyclin-dependentKinasesApprovedForTreatmentOfReceptor-positiveHumanEpidermalGrowthFactorReceptor2-negativeBreastCancer
Other,osteoclasts
cancer,cyclin-dependentKinasesApprovedForTreatmentOfReceptor-positiveHumanEpidermalGrowthFactorReceptorBreastCancer
Other,impactOfHeterogeneityInMolecularDiagnostics
Other,humanCellLines
Other,personalGoal-setting
Other,veryPoor
cancer,outcomeOfBreastCancerPatients
Other,consequentlyPerformed
Other,womenWithBcsTreatedWithTrastuzumabFrom2008To2017
imaging,canUsedDuringDevelopmentOfBreastCtImaging
Other,sexualFunction
cancer,kinasesApprovedForTreatmentOfHormoneReceptor-positiveHumanEpidermalGrowthFactorReceptorAdvancedBreastCancer
Other,results
Other,centralSystemMetastases
Other,inCox'sHazardsSurvivalModelAssociatedWithHazardRatioOf004ForBoneMetastasis
cancer,cyclin-dependentKinasesApprovedForTreatmentOfHumanEpidermalGrowthFactorReceptor2-negativeAdvancedBreastCancer
Other,laboratoryAsOncolyticTherapeutics
Other,cisForSurvival
cancer,breastCancerSubtypes
Other,likelihoodOfBoneMetastasesInWomen
cancer,lowerDegreeOfConcernAboutOvarianCancerRisk
Other,time-enhancementCurvesAtSamplingRate
Other,only1Patient
Other,enhancementDynamics
Other,april2015
Other,searchOfDataOnPalbociclib
cancer,impactOfHeterogeneityForTreatmentSelectionInHer2CancerPatients
Other,lowerLikelihoodOfBoneMetastases
Other,resultFromAdenocarcinomaMetastasisInBoneMarrow
perfusion,perfusionInDifferentTypes
cancer,follow-upViaCancerRegistries
Other,inCox'sProportionalHazardsSurvivalModelAssociatedWithHazardRatioForBoneMetastasis
Other,presentStudy
Other,knowledgeOnCircrnas
Other,realisticPatient-based4dBreastPhantomIncludingTime-varyingContrastEnhancementForSimulation
Other,novelUtilizationOfAcid
Other,sequencing
Other,evidenceOnGoal-setting
Other,potentActivityInIn-vitroModels
Other,loop
Other,mostCommonOralAgentForTreatmentOfPost-menopausalOsteoporosis
Other,expressionOfSelf-renewal-relatedGenes
Other,nanomolarDose
Other,clinicalValue
Other,withDevelopmentHaveDiscoveredInTissues
Other,sexualFunction
Other,inactivationOfGrowthFactorReceptorSignalingPathway
Other,karyotypeWithAberrations
Other,developmentOfStandardizedTherapies
Other,cellGrowthAtConcentrations
Other,outcome
cancer,kinasesApprovedForTreatmentOfHormoneReceptor-positiveHumanEpidermalGrowthFactorReceptor2-negativeBreastCancer
Other,subtype
Other,recorded
Other,extensiveGrowth
multicatheter,interstitialMulticatheterHigh-dose-rateBrachytherapy
Other,impactOfHeterogeneityInDiagnostics
Other,potentialBiomarker
Other,adenocarcinomaMetastasisInBoneMarrowFromSite
cancer,womenWithEarlyBreastCancer
cancer,differentSubtypesOfBreastCancer
Other,combinatorialEffectsOfTamoxifen
Other,cellMigration
Other,patient-based4dDigitalBreastPhantomIncludingTime-varyingContrastEnhancementForSimulation
cancer,cyclin-dependentKinasesApprovedForTreatmentOfHumanEpidermalGrowthFactorReceptorBreastCancerInCombination
Other,proteinLevels
Other,lubrication
Other,cisForProgression-freeSurvival
Other,hazardRatioOf004
cancer,kinasesApprovedForTreatmentOfHumanEpidermalGrowthFactorReceptorBreastCancerInCombination
cancer,effectsOnErCancer
Other,canDeliveredEffectivelyByClinicalTeamWithinPatientEducationAppointment
Other,developmentOfNewGenerationOfTargetedTherapies
Other,4dBreastPhantom
cancer,futureOfCancerImmunotherapy
Other,high
Other,firstCreated
Other,patientsAsValuable
Other,6SubtypesWithMolecularSignaturesWithPrognoses
Other,womenWithBcsTreatedFrom2008To2017
Other,seromaFormationInVariousMethods
Other,finallyCanAlsoSimulatedForTumorModels
Other,relationToGhTreatment
cancer,consideredAsCancerVaccineDeliveryStrategy
Other,updateOfData
imaging,canUsedDuringDevelopmentOfDynamicDedicatedBreastCtImaging
irradiation,acceleratedBreastIrradiation
Other,metastaticOfDisease
Other,ERÎ±66
Other,impactOfHeterogeneityOfErProteinExpression
cancer,kinasesApprovedForTreatmentOfHormoneReceptor-positiveHumanEpidermalGrowthFactorReceptor2-negativeBreastCancerInCombination
Other,threeRepresentations
Other,lowRateOfComplicationsInImplant-basedImmediateBreastReconstruction
Other,biomarker
Other,molecularPathwaysInvolvedInPathogenesisOfProliferation
Other,cdk4/6Inhibitors
Other,usedForAssessment
Other,gathered
Other,impactOfIntratumorHeterogeneityInMolecularDiagnosticsForTreatmentSelection
Other,95EbrtBoost
cancer,kinasesApprovedForTreatmentOfHumanEpidermalGrowthFactorReceptorBreastCancer
Other,patient-based4dDigitalBreastPhantomIncludingTime-varyingContrastEnhancement
Other,lowRateInImplant-basedImmediateBreastReconstruction
Other,egki-1-treatedMice
Other,significantlyShorterDisease-freeSurvival
antioxidant,antioxidantScavenging
cancer,cyclin-dependentKinasesApprovedForTreatmentOfHumanEpidermalGrowthFactorReceptorAdvancedBreastCancerInCombination
Other,considered
Other,4634Â±828Years
cancer,kinasesApprovedForTreatmentOfHormoneReceptor-positiveGrowthFactorReceptor2-negativeBreastCancerInCombination
Other,collectedFrom152BcPatients
Other,realisticPatient-based4dDigitalBreastPhantomIncludingTime-varyingContrastEnhancement
Other,level0
Other,matchingPatterns
Other,effectiveness
perfusion,patient-based4dBreastPhantomIncludingTime-varyingContrastEnhancementForSimulationOfBreastCtPerfusionImaging
cancer,cyclin-dependentKinasesApprovedForTreatmentOfReceptor-positiveHumanEpidermalGrowthFactorReceptor2-negativeAdvancedBreastCancer
Other,combinedImmunofluorescence
cancer,unfavorablePrognosisOfBreastCancerEspecially
Other,immediateBreastReconstruction
Other,hybridization
Other,viableTreatmentOption
Other,mightEffect
Other,canDeliveredEffectivelyByPractice-basedTeamWithinPatientEducationAppointment
Other,riskOfBoneMetastases
Other,mesenchymalMarkerProteins
cancer,cyclin-dependentKinasesApprovedForTreatmentOfGrowthFactorReceptorAdvancedBreastCancer
cancer,estrogenReceptor-positive/humanGrowthFactorReceptor2-negativeBreastCancer
cancer,impactOfIntratumorHeterogeneityInMolecularDiagnosticsForTreatmentSelectionInHer2CancerPatients
Other,activityInIn-vitroModels
Other,hasApprovedForTreatment
cancer,kinasesApprovedForTreatmentOfGrowthFactorReceptor2-negativeBreastCancer
Other,backboneOfTreatment
Other,differencesBeforeBoostAdministration
Other,rateOfComplicationsInImplant-basedImmediateBreastReconstruction
Other,5YearsOfEndocrineTherapyReduced
Other,atEndG1In511Percecnt
Other,peptidesDerivedFromHer2/neuProto-oncogene
Other,inMultivariableCox'sProportionalHazardsSurvivalModelAssociatedWithHazardRatio
Other,differentiallyExpressedGenesBetweenTnbc
Other,free-radicalScavenging
Other,protectiveVaccine
cancer,femalesWithBreastCancer
Other,molecularPathwaysInvolved
Other,realisticPatient-based4dDigitalBreastPhantomIncludingContrastEnhancement
cancer,peptidesDerivedAsVaccineDeliveryModalitiesForTreatmentOfTuboBreastCancerXenograftTumors
Other,searchTool
cancer,breastCancerCellGrowthInBoneMarrowAdiposeTissueNiche
Other,genes
Other,patientSamples
cancer,kinasesApprovedForTreatmentOfReceptor-positiveGrowthFactorReceptorBreastCancer
Other,timeToTreatmentFailureOfPalbociclibInCombinationAsSecond-line
Other,whereComponent
Other,second-leadingCause
Other,405Â±523Years
Other,electrosprayIonizationMassSpectrometry
Other,free-radicalScavengingAgainstCellLines
Other,transcriptionQuantitativePolymeraseChainReaction
Other,humanTnbc
cancer,cyclin-dependentKinasesApprovedForTreatmentOfHormoneReceptor-positiveHumanEpidermalGrowthFactorReceptor2-negativeAdvancedBreastCancerInCombination
Other,measured
Other,developmentOfPotentStandardizedTherapies
Other,wnt/Î²-cateninNuclearTranslocation
perfusion,realisticPatient-based4dDigitalBreastPhantomIncludingContrastEnhancementForSimulationOfBreastCtPerfusionImaging
Other,skinFlapMeasurement
Other,activation
Other,termOverallSurvivalDataAreLacking
Other,molecularDiagnostics
cancer,cyclin-dependentKinasesApprovedForTreatmentOfHormoneReceptor-positiveHumanEpidermalGrowthFactorReceptor2-negativeBreastCancer
cancer,combinationTherapyForPatientsWithBreastCancerDue
cancer,osteoporoticWomenDiagnosedWithEarlyBreastCancer
Other,well-accepted
Other,seromaFormationInVariousMethodsOfFlapFixation
Other,0.006
Other,1984
Other,6SubtypesWithDistinctSignaturesWithPrognoses
Other,potentialRelationship
cancer,kinasesApprovedForTreatmentOfHormoneReceptor-positiveGrowthFactorReceptor2-negativeAdvancedBreastCancer
Other,treatable
Other,cytoscapeSoftware
Other,potentialRelationshipBetweenDysfunction
Other,timeToTreatmentFailureOfPalbociclibInCombinationAsSecond-lineOfTherapy
Other,presentlyLaboratoryAsTherapeutics
Other,level0Doses
Other,resultsOfOtherStudiesPublishedOnAssociation
Other,tumorigenicity
Other,potentialMechanismsInvolvedInDysfunctionMediatedByEstrogenReceptorSubtypes
perfusion,4dBreastPhantomIncludingTime-varyingContrastEnhancementForSimulationOfDedicatedBreastCtPerfusionImaging
cancer,cyclin-dependentKinasesApprovedForTreatmentOfReceptor-positiveGrowthFactorReceptor2-negativeAdvancedBreastCancer
cancer,publishedFemalesWithBreastCancer
Other,kinasesApprovedForTreatmentInCombinationWithFulvestrantInPostmenopausalWomenWithDiseaseProgressionFollowingEndocrineTherapy
Other,treatmentOfAdvancedHrPositiveHighlighting
Other,20-60Îg/ml
Other,upregulationOfE-cadherinExpressionInLungTissue
Other,withDevelopmentOfHigh-throughputSequencingHaveDiscoveredInTissues
Other,knowledgeOfRecurrenceBiology
cancer,cyclin-dependentKinasesApprovedForTreatmentOfReceptor-positiveHumanEpidermalGrowthFactorReceptor2-negativeBreastCancerInCombination
Other,cyclin-dependentKinasesApprovedForTreatmentInCombinationWithFulvestrantInPostmenopausalWomen
Other,lowRateInBreastReconstruction
cancer,lowerLikelihoodOfBoneMetastasesInPostmenopausalWomenWithEarlyBreastCancer
Other,managementChallengesInTreatmentOfAdvancedHrPositive
Other,81PercecntForMammography
cancer,cyclin-dependentKinasesApprovedForTreatmentOfHormoneReceptor-positiveGrowthFactorReceptor2-negativeAdvancedBreastCancerInCombination
Other,alsoAssessed
Other,onlyBiomarker
Other,efficacyOfPalbociclibInPatientsPretreated
Other,mda-mb-231Cells
cancer,kinasesApprovedForTreatmentOfReceptor-positiveGrowthFactorReceptor2-negativeBreastCancerInCombination
multicatheter,interstitialFractionatedMulticatheterHigh-dose-rateBrachytherapy
Other,futureStudies
Other,patientIntoSkin
cancer,developmentOfNewGenerationOfTargetedTherapiesForAdvancedBreastCancer
Other,commonOralAgent
Other,willRandomlyAllocatedToOneOfThreeTreatmentArms
Other,potentActivityInModels
cancer,kinasesApprovedForTreatmentOfHumanEpidermalGrowthFactorReceptor2-negativeBreastCancer
Other,resultFromAdenocarcinomaMetastasisFromUnknownSite
Other,5YearsWith5Years
Other,peptidesDerivedFromHer2/neuProto-oncogeneAsVaccineDeliveryModalities
cancer,kinasesApprovedForTreatmentOfGrowthFactorReceptor2-negativeAdvancedBreastCancerInCombination
Other,threeDifferentMetrics
Other,significantDifferencesBetweenTumor
antioxidant,antioxidantScavengingAgainstBreast-cancerCellLines
Other,90PercecntAccuracy
cancer,thusMayFactorInProgressionOfBreastCancer
Other,likely
Other,inPhageDisplayImmunotherapyPresentedByFusions
Other,fibroblastic-to-epithelialPhenotype
Other,mightTherapeuticEffect
Other,escalated
Other,sideEffectsOfEndocrineTherapy
Other,evenPresenceOfInsulin
Other,significantlyOlder
Other,pivotalRoleOnIrSignallingInMcf-7
Other,mechanisms
Other,tolerability
Other,due
cancer,kinasesApprovedForTreatmentOfHormoneReceptor-positiveGrowthFactorReceptor2-negativeBreastCancer
Other,world
imaging,canUsedDuringDevelopmentOfDynamicDedicatedBreastCtImagingForOptimization
Other,marrowMetastasisFromTumors
Other,realistic4dDigitalBreastPhantom
Other,effects
Other,sexuality
Other,promiseForFutureDevelopment
cancer,kinasesApprovedForTreatmentOfReceptor-positiveHumanEpidermalGrowthFactorReceptorAdvancedBreastCancer
Other,canDeliveredByClinicalTeamWithinPatientEducationAppointment
cancer,peptidesDerivedAsVaccineDeliveryModalitiesForTreatmentOfTuboBreastCancerXenograftTumorsOfBalb/cMice
antioxidant,antioxidantAgainstHumanBreast-cancerCellLines
Other,free-radicalScavengingAgainstBreast-cancerCellLines
cancer,novelUtilizationOf3-o-p-coumaroyltormenticAcidForBreastCancerTherapy
cancer,kinasesApprovedForTreatmentOfHumanEpidermalGrowthFactorReceptorAdvancedBreastCancer
cancer,kinasesApprovedForTreatmentOfHormoneReceptor-positiveGrowthFactorReceptorBreastCancer
Other,insight
Other,patient-reportedOutcomes
Other,poorOutcome
Other,cox'sHazardsSurvivalModel
cancer,kinasesApprovedForTreatmentOfGrowthFactorReceptor2-negativeAdvancedBreastCancer
Other,expressionOfTdo2
cancer,hasApprovedForTreatmentOfHr-positive/her2-negativeBreastCancerPatients
Other,nervousSystemMetastasesAmongMalignancies
Other,inCox'sHazardsSurvivalModelAssociatedWithHazardRatio
Other,2-negative
cancer,kinasesApprovedForTreatmentOfReceptor-positiveGrowthFactorReceptorAdvancedBreastCancerInCombination
Other,greatPromiseInFuture
Other,cellDeathIndex
Other,alcohol
Other,nervousSystemMetastasesAmongSevereMalignancies
cancer,combinationTherapyForPatientsWithBreastCancer
Other,activityInModels
Other,resultFromDiffuseAdenocarcinomaMetastasisFromUnknownSite
Other,patient-based4dBreastPhantomIncludingContrastEnhancementForSimulation
Other,ERÎ±
Other,realisticBeliefs
Other,symptomsAssociatedWithEarlyMenopause
Other,diffuseAdenocarcinomaMetastasisInBoneMarrowFromSite
cancer,otherBreastCancerSubtypes
Other,evenCanTreatedWithHormonalReplacementTherapies
Other,realisticPatient-based4dBreastPhantomIncludingContrastEnhancementForSimulation
Other,5YearsWith5YearsOfTamoxifen
Other,deadSpace
cancer,humanEpidermalGrowthFactorReceptor2-negativeMetastaticBreastCancerPatients
Other,termsOfHistology
ESR1,plasmaEsr1MutationsInMbcPatients
Other,applicationsOfOvs
Other,mayManagedWithDoseReduction
Other,unfavourable
antioxidant,antioxidantFree-radicalScavengingAgainstHumanCellLines
Other,ubiquitinProteasomeSystem
cancer,kinasesApprovedForTreatmentOfReceptor-positiveGrowthFactorReceptorBreastCancerInCombination
Other,in-vitroModels
Other,whenExposedToSingleTamoxifen
Other,mostCommonAgentForTreatmentOfOsteoporosis
Other,furtherInvestigation
Other,satisfaction
Other,furthermoreMayPotentialTherapeuticTargetInEscc
cancer,combinationTherapyForPatientsWithAdvancedBreastCancer
cancer,kinasesApprovedForTreatmentOfHumanEpidermalGrowthFactorReceptorAdvancedBreastCancerInCombination
Other,keyDriversOfProliferationInHormoneReceptor
prognosis,plannedPrognosisDiscussion
cancer,subtypeOfBreastCancerWithPoorOutcome
imaging,canUsedDuringDevelopmentOfDynamicBreastCtImagingForOptimizationOfImageAcquisition
Other,markerProteins
Other,cochraneLibraryDatabases
Other,biologicalSignificance
cancer,lowerDegreeOfConcernAboutCancerRisk
Other,whereComponentOfStudy
Other,moreoverRelated
Other,pathwaysInvolved
Other,canSimulated
Other,effectsOfTherapy
Other,search
Other,scavengingAgainstHumanBreast-cancerCellLines
Other,implants
Other,threeDifferentMetricsOfMortality
Other,satisfied
Other,therapyResistance
cancer,kinasesApprovedForTreatmentOfReceptor-positiveHumanEpidermalGrowthFactorReceptor2-negativeBreastCancer
Other,expectedEnhancement
cancer,developmentOfNewGenerationOfTherapiesForBreastCancer
Other,controlled
Other,rateInBreastReconstruction
Other,updateOfDataOnPharmacodynamics
Other,cyclin-dependentKinasesApprovedForTreatment
prognosis,prognosisDiscussionCommunicationSkills
Other,willRandomlyAllocatedToOneThreeTreatmentArmsConsisting
cancer,kinasesApprovedForTreatmentOfReceptor-positiveGrowthFactorReceptorAdvancedBreastCancer
Other,convolution
Other,opaeConcentration
Other,activationOfP13k/akt/mtorSignalingPathway
irradiation,scannedBeforeChemotherapy
cancer,kinasesApprovedForTreatmentOfReceptor-positiveHumanEpidermalGrowthFactorReceptor2-negativeAdvancedBreastCancer
cancer,cyclin-dependentKinasesApprovedForTreatmentOfHumanEpidermalGrowthFactorReceptorBreastCancer
Other,mayFactor
imaging,canUsedDuringDevelopmentOfContrast-enhancedDedicatedBreastCtImaging
Other,review
cancer,subtypeOfBreastCancerWithOutcome
Other,pathwaysInvolvedInPathogenesisOfProliferation
Other,resultFromDiffuseAdenocarcinomaMetastasisFromPrimarySite
cancer,threeVisualRepresentationsOfSeer-basedBreastCancerPatientCohorts
cancer,2231MrnaProfilesOfPatientsWithEr-positive/humanEpidermalGrowthFactorReceptor2-negativeBreastCancer
cancer,outcomeOfHr-positiveBreastCancerPatients
cancer,mayFactorInProgressionOfBreastCancer
Other,onlyValidatedBiomarker
cancer,clinicalOutcomeOfBreastCancerPatientsTreated
cancer,promiseInFutureOfCancerImmunotherapy
Other,interventionFeasibility
Other,resultsOfOtherStudiesPublishedOnAssociationOfHypofractionation
Other,oralAgentForTreatmentOfPost-menopausalOsteoporosis
cancer,increasinglyConsideredAsNewCancerVaccineDeliveryStrategy
Other,oralAgentForTreatmentOfOsteoporosis
Other,tissueSectionsFollowedByValidatedComputationalApproach
cancer,cancerTreatment
cancer,patientsWithEarlyBreastCancer
Other,life
Other,erÎ±TranscriptionCycle
Other,canDeliveredByPractice-basedTeamWithinPatientEducationAppointment
cancer,kinasesApprovedForTreatmentOfHormoneReceptor-positiveGrowthFactorReceptorAdvancedBreastCancerInCombination
cancer,fewPeptidesDerivedAsVaccineDeliveryModalitiesForTreatmentOfTuboBreastCancerXenograftTumors
perfusion,realistic4dBreastPhantomIncludingContrastEnhancementForSimulationOfDedicatedBreastCtPerfusionImaging
Other,inhibited
cancer,developmentOfNewGenerationOfTargetedTherapiesForBreastCancer
Other,expected
Other,increase
Other,sensitivityToTam
Other,insightIntoTheirPriorities
Other,aroniaExtracts
cancer,cyclin-dependentKinasesApprovedForTreatmentOfReceptor-positiveHumanEpidermalGrowthFactorReceptor2-negativeAdvancedBreastCancerInCombination
Other,combinationTherapyDueToToxicities
Other,curvesAtDesiredSamplingRate
Other,roleOnIrSignalling
Other,evidenceOnGoal-settingAmongWomen
Other,keyDrivers
Other,objectiveBreastCosmesisScale
Other,stage
Other,boneMetastases
Other,role
Other,hazardRatios
cancer,kinasesApprovedForTreatmentOfReceptor-positiveHumanEpidermalGrowthFactorReceptorAdvancedBreastCancerInCombination
prognosis,veryPoorPrognosis
Other,lateRecurrencesInPatientsWithTumors
Other,AC
Other,realisticPatient-based4dDigitalBreastPhantomIncludingTime-varyingContrastEnhancementForSimulation
Other,tumorGrowthReductionInMice
cancer,cyclin-dependentKinasesApprovedForTreatmentOfHormoneReceptor-positiveGrowthFactorReceptor2-negativeBreastCancerInCombination
perfusion,4dDigitalBreastPhantomIncludingTime-varyingContrastEnhancementForSimulationOfDedicatedBreastCtPerfusionImaging
cancer,kinasesApprovedForTreatmentOfHormoneReceptor-positiveGrowthFactorReceptorAdvancedBreastCancer
Other,agentForTreatmentOfOsteoporosis
Other,atEndOfRtTreatmentG1In511PercecntOfPatients
cancer,combinationTherapyForPatientsWithAdvancedBreastCancerDueToToxicities
Other,numberConsist
Other,performed
Other,tamoxifenAlone
Other,combinationTherapyDue
Other,useful
Other,clinicalImpactOfHeterogeneity
Other,higherProbability
Other,cellGrowthOfMcf-7CellsAtConcentrations
Other,IRs
Other,6SubtypesWithDistinctMolecularSignaturesWithPrognoses
Other,curves
Other,favorableBoneMarrowMicroenvironmentForTumorCells
Other,cellularProliferation
perfusion,patient-based4dDigitalBreastPhantomIncludingTime-varyingContrastEnhancementForSimulationOfBreastCtPerfusionImaging
Other,cyclin-dependentKinases
Other,presentedByFusions
Other,important
cancer,combinationTherapyForPatientsWithRecurrentBreastCancer
Other,ovTherapy
Other,august2010
cancer,impactOfIntratumorHeterogeneityInDiagnosticsForTreatmentSelectionInHer2CancerPatients
cancer,combinationTherapyForPatientsWithRecurrentBreastCancerDueToToxicities
Other,cell-deathHistopathologyOfTumors
cancer,usefulForEarlyDiagnosisOfCancer
Other,tolerabilityWithEri
cancer,cyclin-dependentKinasesApprovedForTreatmentOfHumanEpidermalGrowthFactorReceptor2-negativeAdvancedBreastCancerInCombination
Other,created
Other,resultsOfStudiesPublished
Other,calculated
antioxidant,excellentAntioxidantAgainstHumanBreast-cancerCellLines
Other,beliefs
Other,causeOfDeathInWomenWorldwide
Other,mostCommonOralAgentForTreatmentOfOsteoporosis
Other,mouseXenograftModel
Other,futureDevelopment
Other,6SubtypesWithDistinctMolecularSignatures
Other,theirPotentialImplications
cancer,theirPotentialImplicationsOnBreastCancer
Other,searchInAscoProceedings
Other,agentForTreatmentOfPost-menopausalOsteoporosis
Other,cyclin-dependentKinasesApprovedForTreatmentInCombinationWithFulvestrantInPostmenopausalWomenWithDiseaseProgressionFollowingEndocrineTherapy
Other,effectsOfTamoxifen
Other,tamoxifenResistance
Other,time-enhancementCurvesAtDesiredSamplingRate
Other,isolation
Other,evaluationMethods
Other,2Years
Other,surveillancePrograms
Other,514Women
Other,time-enhancementCurves
cancer,combinationTherapyForPatientsWithRecurrentBreastCancerDue
cancer,utilizationOf3-o-p-coumaroyltormenticAcidForBreastCancerTherapy
Other,potentialTherapeuticTargets
Other,treatmentWithAc
Other,fewPeptidesDerivedFromHer2/neuProto-oncogene
Other,isWith
Other,expressionOfApoptoticProteins
Other,presented
Other,resultFromDiffuseAdenocarcinomaMetastasisInBoneMarrow
Other,thusMayFactorInProgression
Other,usefulForDiagnosis
Other,origin
Other,recurrencesInPatients
Other,fewPeptidesDerivedFromHer2/neuProto-oncogeneAsVaccineDeliveryModalities
Other,efficacy
cancer,cyclin-dependentKinasesApprovedForTreatmentOfReceptor-positiveHumanEpidermalGrowthFactorReceptorAdvancedBreastCancerInCombination
Other,realistic4dBreastPhantom
Other,scavengingAgainstHumanCellLines
Other,observedWnt/Î²-cateninTranslocation
Other,times
Other,whenExposed
cancer,kinasesApprovedForTreatmentOfReceptor-positiveGrowthFactorReceptor2-negativeAdvancedBreastCancerInCombination
cancer,threeRepresentationsOfSeer-basedBreastCancerPatientCohorts
cancer,consideredAsNewCancerVaccineDeliveryStrategy
Other,wechslerMemoryTest
cancer,developmentOfGenerationOfTherapiesForBreastCancer
Other,oncosphere
cancer,kinasesApprovedForTreatmentOfGrowthFactorReceptorAdvancedBreastCancer
cancer,cyclin-dependentKinasesApprovedForTreatmentOfHumanEpidermalGrowthFactorReceptor2-negativeBreastCancerInCombination
cancer,increasinglyConsideredAsCancerVaccineDeliveryStrategy
cancer,cyclin-dependentKinasesApprovedForTreatmentOfReceptor-positiveGrowthFactorReceptorAdvancedBreastCancer
Other,fewPeptides
Other,in-houseFlowchart
cancer,vaccineAgainstCancer
irradiation,partialBreastIrradiation
perfusion,chemotherapyInjection
prognosis,unfavorablePrognosisEspecially
Other,humanBreast-cancerCellLines
Other,G1
Other,sparse
Other,differencesBetweenViableTumor
Other,ir-aIsoform
cancer,cyclin-dependentKinasesApprovedForTreatmentOfGrowthFactorReceptor2-negativeAdvancedBreastCancer
Other,induced
Other,pivotalRoleOfIrAntagonistS961OnIrSignalling
imaging,canUsedDuringDevelopmentOfDynamicContrast-enhancedBreastCtImagingForOptimization
antioxidant,excellentAntioxidantAgainstHumanCellLines
Other,MCF-7
Other,sizeOfSpheroidColonies
Other,boneMarrow
imaging,canUsedDuringDevelopmentOfBreastCtImagingForOptimization
Other,post-menopausalWomen
cancer,cyclin-dependentKinasesApprovedForTreatmentOfGrowthFactorReceptor2-negativeAdvancedBreastCancerInCombination
Other,decreasedProliferation
Other,finallyCanAlsoSimulated
Other,transcription
cancer,kinasesApprovedForTreatmentOfGrowthFactorReceptorBreastCancer
Other,eligibleStudies
Other,longTermOverallSurvivalDataAreLacking
Other,boneMarrowMicroenvironmentForTumorCells
cancer,clinicalOutcomeOfHr-positiveBreastCancerPatientsTreated
Other,marrowMetastasis
Other,enhancement
Other,timeToTreatmentFailureOfPalbociclibInCombinationWithLetrozoleAsSecond-line
Other,markerProteinsLikeOccludin
cancer,developmentOfGenerationOfTherapiesForAdvancedBreastCancer
Other,extent
Other,excessiveToxicity
Other,mostCommonAgentForTreatment
Other,haveImplicatedInPromotion
Other,new
Other,aspectsOfPhenotype
Other,osHr
Other,enhancementOfTissuesConsistentWithGivenInputParameters
Other,responsible
Other,breastTumourCells
perfusion,realistic4dDigitalBreastPhantomIncludingContrastEnhancementForSimulationOfDedicatedBreastCtPerfusionImaging
cancer,cyclin-dependentKinasesApprovedForTreatmentOfHormoneReceptor-positiveGrowthFactorReceptorAdvancedBreastCancer
Other,patientsWithHormoneReceptor
Other,wms-rIndicesBetweenTwoStudies
Other,diffuseAdenocarcinomaMetastasisInBoneMarrowFromPrimarySite
Other,clinicalOutcomes
Other,centralNervousSystemMetastases
Other,combinationTherapy
Other,patient-based4dDigitalBreastPhantomIncludingContrastEnhancementForSimulation
Other,bcctcoreSoftware
cancer,cyclin-dependentKinasesApprovedForTreatmentOfGrowthFactorReceptor2-negativeBreastCancer
Other,normalCellGrowth
Other,pivotalRoleOfIrAntagonistS961
Other,women'sSexualFunction
Other,flowchart
Other,erÎ±ProteinLevels
Other,increasinglyConsidered
Other,diffuseAdenocarcinomaMetastasisInBoneMarrowFromUnknownSite
Other,searchOfDataOnPalbociclibInPubmed
Other,canSimulatedForTumorModels
Other,highRecurrenceRiskBeyond5YearsAfterDiagnosis
Other,sensitivityOfBcMad-mb-231CellsToTam
Other,BT
cancer,cyclin-dependentKinasesApprovedForTreatmentOfReceptor-positiveGrowthFactorReceptorBreastCancer
cancer,impactInDiagnosticsForTreatmentSelectionInHer2CancerPatients
Other,humanEpidermalGrowthFactorReceptor2
cancer,cyclin-dependentKinasesApprovedForTreatmentOfReceptor-positiveHumanEpidermalGrowthFactorReceptorAdvancedBreastCancer
Other,kinasesApprovedForTreatmentInCombination
Other,71Percecnt
Other,cyclin-dependentKinasesApprovedForTreatmentInCombinationWithFulvestrantInWomenWithDiseaseProgression
Other,adenocarcinomaMetastasisInBoneMarrowFromUnknownSite
cancer,cyclin-dependentKinasesApprovedForTreatmentOfReceptor-positiveGrowthFactorReceptor2-negativeBreastCancer
Other,lowerLikelihoodOfBoneMetastasesInPostmenopausalWomen
Other,fdaWebsite
Other,knowledge
Other,function
Other,convolutionBetweenInputFunction
Other,resultsOfOtherStudies
Other,proliferation
Other,lateRecurrence
Other,patient-based4dBreastPhantomIncludingTime-varyingContrastEnhancement
Other,ovTherapyWithImmuneCheckpointInhibitors
Other,multivariableCox'sProportionalHazardsSurvivalModel
cancer,cyclin-dependentKinasesApprovedForTreatmentOfHormoneReceptor-positiveHumanEpidermalGrowthFactorReceptorBreastCancer
Other,2231MrnaProfiles
Other,5YearsOfTamoxifenTherapy
Other,canUsedForOptimizationOfImageAcquisition
imaging,canUsedDuringDevelopmentOfDynamicContrast-enhancedDedicatedBreastCtImagingForOptimizationOfImageAcquisition
Other,kaplan-meierPlotterSurvivalAnalysisTool
Other,vital
Other,complication
Other,combinatorialEffects
Other,severalAspectsOfMalignantPhenotypeIncludingCellProliferation
Other,probabilityOfRelapse
Other,morphology
Other,developmentOfGeneration
Other,groupNab
Other,developed
cancer,cyclin-dependentKinasesApprovedForTreatmentOfGrowthFactorReceptorBreastCancerInCombination
Other,measureAt05ÎtSaturationAmplitude
Other,coactivators
cancer,modalitiesInCancerImmuneTherapeutics
Other,rate
Other,canDeliveredByTeam
Other,evidenceOnPersonalGoal-setting
Other,diffuseAdenocarcinomaMetastasisInBoneMarrowFromUnknownPrimarySite
cancer,estrogenReceptor-positive/humanGrowthFactorReceptorBreastCancer
Other,theirAssociationWithRecurrenceRisk
Other,repressedByTam
Other,95PercecntCisForSurvival
Other,earlyRecurrenceRisk
cancer,kinasesApprovedForTreatmentOfReceptor-positiveHumanEpidermalGrowthFactorReceptor2-negativeBreastCancerInCombination
Other,poor
Other,doublingTimes
Other,excellent/good
Other,withDevelopmentHaveDiscoveredInTumorousTissues
irradiation,adjuvantBreastIrradiation
Other,analysis
Other,g2/mPhase
Other,mastectomy
Other,ebrtGroup
Other,example
cancer,likelihoodOfBoneMetastasesInPostmenopausalWomenWithBreastCancer
Other,currentKnowledgeOnHumanCircrnas
Other,potentialTherapeuticTargetsForTnbc
Other,willRandomlyAllocatedToOneThreeTreatmentArmsConsistingOfFlapFixation
Other,adenocarcinomaMetastasisInBoneMarrowFromPrimarySite
Other,measure
Other,implicationsOfStudy
Other,followed-up
Other,endocrineTherapy
cancer,occurringCancer
imaging,canUsedDuringDevelopmentOfDynamicContrast-enhancedBreastCtImaging
Other,rateInImplant-basedImmediateBreastReconstruction
Other,repressedAfterSilencingLincrna-ror
Other,validatedBiomarker
Other,resultFromAdenocarcinomaMetastasisFromSite
Other,potential
Other,demonstratedByUpregulationOfE-cadherinExpressionInBiopsiedLungTissue
Other,deathInWomenWorldwide
Other,visits
Other,silenceLincrna-ror
Other,aberrations
Other,commonAgent
Other,ERI
Other,analyzed
Other,511PercecntOfPatients
Other,lowRateOfComplications
Other,expressionOfLincrna-ror
Other,groupAb
Other,impactInDiagnosticsForTreatmentSelection
Other,termsOfAcute
cancer,likelihoodOfBoneMetastasesInWomenWithEarlyBreastCancer
Other,potentialPredictiveBiomarkerForCdk4/6Inhibitors
Other,twoGroupsIncluding196PatientsInGroupAb
Other,combinationTherapyForPatientsDueToHematologicalToxicities
Other,efficacyOfPalbociclibInPatients
Other,inMultivariableCox'sProportionalHazardsSurvivalModelAssociatedWithHazardRatioOf004ForBoneMetastasis
Other,resultFromAdenocarcinomaMetastasisFromUnknownPrimarySite
Other,inCox'sProportionalHazardsSurvivalModelAssociatedWithHazardRatioOf004
cancer,lowerLikelihoodOfBoneMetastasesInWomenWithBreastCancer
Other,therapeutic
Other,near-tetraploidKaryotypeWithStructuralAberrations
cancer,cyclin-dependentKinasesApprovedForTreatmentOfHormoneReceptor-positiveGrowthFactorReceptor2-negativeAdvancedBreastCancer
Other,increasingOpaeConcentrationUpTo240G/ml
Other,mostCommonAgentForTreatmentOfPost-menopausalOsteoporosis
Other,likelihood
Other,97Percecnt
Other,sox4Promoter
Other,majorComponent
Other,95PercecntCisForProgression-freeSurvival
Other,interesting
cancer,combinationTherapyForPatientsWithAdvancedRecurrentBreastCancerDue
Other,evidenceOnPersonalGoal-settingAmongWomen
Other,systemMetastasesAmongMalignancies
Other,resultFromDiffuseAdenocarcinomaMetastasisFromSite
Other,earlySurgicalMenopause
cancer,reductionInBreastCancerGrowth
cancer,cyclin-dependentKinasesApprovedForTreatmentOfGrowthFactorReceptorBreastCancer
Other,disease
Other,womenWithBcs
Other,utilizationOfAcid
Other,unclear
Other,lowerDegreeOfConcern
Other,detected
Other,mesenchymalMarkerProteinsLikeN-cadherin
Other,monoclonalAntibody
Other,tissueSectionsFollowedByValidatedApproach
Other,characteristicsOfParentTumor's
cancer,earlyBreastCancer
Other,earlyMenopause
Other,observedWnt/Î²-cateninNuclearTranslocation
Other,clinic
Other,hydatidCyst
Other,detectedBy3
Other,cyclin-dependentKinasesApprovedForTreatmentInCombinationWithFulvestrant
Other,174Brca1-2MutationCarriers
perfusion,realistic4dBreastPhantomIncludingTime-varyingContrastEnhancementForSimulationOfDedicatedBreastCtPerfusionImaging
Other,2Ã2Mixed
Other,thusMayFactor
Other,information
Other,resultFromDiffuseAdenocarcinomaMetastasisFromUnknownPrimarySite
cancer,cyclin-dependentKinasesApprovedForTreatmentOfHumanEpidermalGrowthFactorReceptor2-negativeBreastCancer
Other,investigatedInVivo
Other,herceptin
Other,demonstratedByUpregulation
cancer,evidenceOnGoal-settingAmongWomenWithBreastCancerDiagnosis
prognosis,prognosis
Other,whenExposedToTamoxifen
Other,willAllocatedToOneOfThreeTreatmentArms
Other,6SubtypesWithDistinctSignatures
Other,kinasesApprovedForTreatment
cancer,combinationTherapyForPatientsWithAdvancedRecurrentBreastCancer
Other,hydatidCystLocalizedToLiver
Other,models
Other,novelUtilization
cancer,breastCancerGrowth
Other,existingEvidence
Other,8-12H
Other,convolutionBetweenArterialInputFunction
cancer,cyclin-dependentKinasesApprovedForTreatmentOfGrowthFactorReceptorAdvancedBreastCancerInCombination
Other,drug-resistant
Other,haveLinkedToPathogenesis
Other,aspectsIncludingCellProliferation
Other,added
cancer,kinasesApprovedForTreatmentOfReceptor-positiveHumanEpidermalGrowthFactorReceptorBreastCancerInCombination
cancer,impactInMolecularDiagnosticsForTreatmentSelectionInHer2CancerPatients
Other,yearsOfResearch
Other,6SubtypesWithMolecularSignatures
Other,cyclin-dependentKinasesApprovedForTreatmentInCombination
Other,realisticPatient-based4dDigitalBreastPhantomIncludingContrastEnhancementForSimulation
Other,cystLocalized
Other,evaluationMethodsForQuality
Other,grade3Mucositis
antioxidant,antioxidantAgainstHumanCellLines
Other,setting
Other,patientsTreatedWithGhAfterCranialRadiotherapy
Other,mostDiagnosedDiseases
Other,impactOfIntratumorHeterogeneity
Other,targets
Other,years
Other,kunitzTypeProteaseInhibitorFamily
Other,atLeast2YearFollow-up
cancer,cancerImmuneTherapeutics
Other,tissues
antioxidant,antioxidantFree-radicalScavengingAgainstHumanBreast-cancerCellLines
Other,kinases
cancer,hasApprovedForTreatmentOfBreastCancerPatients
Other,willAllocatedToOneThreeTreatmentArmsConsisting
Other,escalatedTo14Mg/m2ForGem
Other,timeToTreatmentFailure
Other,inPhageDisplayImmunotherapyPresented
Other,numberConsistOfNumber
cancer,kinasesApprovedForTreatmentOfHormoneReceptor-positiveHumanEpidermalGrowthFactorReceptorBreastCancerInCombination
cancer,newModalitiesInCancerImmuneTherapeutics
Other,lungMetastasis
cancer,breastCancerCellGrowth
Other,potentialTargets
Other,qualityOfLife
Other,searchOfDataOnPalbociclibInPubmedInAscoProceedings
Other,poorClinicalOutcomes
Other,6SubtypesWithSignaturesWithPrognoses
cancer,kinasesApprovedForTreatmentOfHormoneReceptor-positiveHumanEpidermalGrowthFactorReceptor2-negativeAdvancedBreastCancerInCombination
Other,mayPotentialTarget
Other,adenocarcinomaMetastasis
Other,adiposeTissue
Other,ofParentTumor
Other,patientsPretreatedWithOneLinesOfEndocrineTherapy
Other,survival
cancer,cyclin-dependentKinasesApprovedForTreatmentOfReceptor-positiveGrowthFactorReceptorAdvancedBreastCancerInCombination
Other,seromaFormation
perfusion,4dDigitalBreastPhantomIncludingContrastEnhancementForSimulationOfDedicatedBreastCtPerfusionImaging
Other,resultsOfStudiesPublishedOnAssociationOfHypofractionation
Other,continuedPresence
Other,searchOfDataInFdaWebsite
Other,immuneCheckpointInhibitors
cancer,cyclin-dependentKinasesApprovedForTreatmentOfHormoneReceptor-positiveHumanEpidermalGrowthFactorReceptorAdvancedBreastCancer
Other,womenWithHer2-positiveBcsTreated
Other,aimed
Other,presentedByGeneticFusionsToPhageCoatProteins
Other,greatPromise
Other,space
Other,antimicrobial
Other,adhesiveTissueGlues
cancer,cyclin-dependentKinasesApprovedForTreatmentOfHormoneReceptor-positiveHumanEpidermalGrowthFactorReceptor2-negativeBreastCancerInCombination
Other,molecularTargets
Other,potentialMechanismsInvolvedInMitochondrialDysfunctionMediated
Other,canDeliveredEffectivelyByClinicalTeamWithinSemi-structuredPatientEducationAppointment
Other,timeToTreatmentFailureInCombinationWithLetrozole
Other,implications
Other,impact
Other,impactOfIntratumorHeterogeneityInDiagnosticsForTreatmentSelection
cancer,cyclin-dependentKinasesApprovedForTreatmentOfHormoneReceptor-positiveHumanEpidermalGrowthFactorReceptorAdvancedBreastCancerInCombination
Other,expressionOfMitochondrialProteins
Other,significantReduction
Other,mainAdjuvantTreatment
Other,excitement
Other,cd44high/cd24lowSubpopulation
cancer,cancerPrevention
Other,haveDiscovered
Other,RNAi
cancer,developmentOfGenerationOfTargetedTherapiesForBreastCancer
Other,inModel
Other,mechanismsOfResistance
imaging,accuracyForMriPreoperativeEvaluation
brachytherapy,brachytherapy
Other,idealStrategy
Other,adenocarcinomaMetastasisInBoneMarrowFromUnknownPrimarySite
Other,mostCommonOralAgentForTreatment
Other,mayManaged
Other,kinasesApprovedForTreatmentInCombinationWithFulvestrantInPostmenopausalWomen
cancer,kinasesApprovedForTreatmentOfHormoneReceptor-positiveHumanEpidermalGrowthFactorReceptorBreastCancer
Other,backboneOfTreatmentInCases
Other,hazardRatioForBoneMetastasis
Other,reverseTranscriptionQuantitativePolymeraseChainReaction
Other,developmentOfNewGenerationOfTherapies
Other,excellent
Other,supportiveCare
Other,clinicalImpactOfIntratumorHeterogeneityOfErProteinExpression
Other,migration
Other,intensiveClinicalSurveillancePrograms
Other,nudeMouseXenograftModel
Other,resultsOfStudiesPublishedOnAssociation
Other,exposed
perfusion,patient-based4dBreastPhantomIncludingContrastEnhancementForSimulationOfBreastCtPerfusionImaging
Other,upregulationOfE-cadherinExpression
Other,showInvasivenessInMice
Other,616PercecntInGroupAb
Other,timeToTreatmentFailureOfPalbociclibInCombinationWithLetrozoleAsSecond-lineOfTherapy
Other,diffuseAdenocarcinomaMetastasis
Other,breastConservingTherapy
Other,significantTumorGrowthReduction
perfusion,realisticPatient-based4dDigitalBreastPhantomIncludingTime-varyingContrastEnhancementForSimulationOfBreastCtPerfusionImaging
Other,markerProteinsLikeN-cadherin
Other,severalAspectsOfPhenotype
Other,desire
Other,leadingCauseOfDeathInWomenWorldwide
Other,resultFromAdenocarcinomaMetastasisFromPrimarySite
Other,resultsOfOtherStudiesPublished
Other,inMultivariableCox'sHazardsSurvivalModelAssociatedWithHazardRatioOf004
brachytherapy,interstitialFractionatedBrachytherapy
Other,potentialMechanismsInvolvedInDysfunctionMediatedBySeveralEstrogenReceptorSubtypes
cancer,2231MrnaProfilesOfPatientsWithEr-positive/humanEpidermalGrowthFactorReceptorBreastCancer
Other,canUsedDuringDevelopmentForOptimizationOfImageAcquisition
imaging,canUsedDuringDevelopmentOfContrast-enhancedBreastCtImagingForOptimizationOfImageAcquisition
Other,anti-estrogenTherapyWithEstrogenReceptorModulators
Other,furthermoreMayPotentialTargetInEscc
Other,lowRateOfComplicationsInBreastReconstruction
cancer,combinatorialEffectsOfTamoxifenOnErCancer
Other,scanned
Other,possibleInfluenceOnOutcomes
perfusion,realistic4dDigitalBreastPhantomIncludingTime-varyingContrastEnhancementForSimulationOfDedicatedBreastCtPerfusionImaging
Other,canTreatedWithReplacementTherapies
Other,63Months
Other,powerActivities
irradiation,adjuvantAcceleratedPartialBreastIrradiation
cancer,cyclin-dependentKinasesApprovedForTreatmentOfHormoneReceptor-positiveHumanEpidermalGrowthFactorReceptor2-negativeAdvancedBreastCancer
Other,canDeliveredByClinicalTeamWithinSemi-structuredPatientEducationAppointment
Other,differences
cancer,hrPositiveBreastCancer
Other,developmentOfNewGeneration
Other,canDeliveredEffectivelyByTeam
Other,scored
Other,multicenter
cancer,kinasesApprovedForTreatmentOfReceptor-positiveHumanEpidermalGrowthFactorReceptorBreastCancer
Other,changed
Other,itsTranscription
Other,possibleInfluence
cancer,cyclin-dependentKinasesApprovedForTreatmentOfHormoneReceptor-positiveGrowthFactorReceptorBreastCancer
Other,evenCanTreatedWithReplacementTherapies
imaging,canUsedDuringDevelopmentOfContrast-enhancedDedicatedBreastCtImagingForOptimization
Other,evaluatedIn90EsccTissueSamplesByImmunohistochemistry
Other,endOfRtTreatment
Other,mayPotentialTherapeuticTarget
Other,grade3OralMucositis
Other,informationOfBreast
Other,easy
Other,difficult
Other,peptides
Other,cellProliferation
Other,canDeliveredEffectivelyByPractice-basedTeamWithinSemi-structuredPatientEducationAppointment
prognosis,poorPrognosis
Other,peptidesDerivedAsVaccineDeliveryModalitiesForTreatment
cancer,usefulForEarlyDiagnosisOfBreast/ovarianCancer
Other,timeToTreatmentFailureOfPalbociclibAsSecond-line
Other,recurrenceRiskBeyond5YearsAfterDiagnosis
Other,potentialMechanismsInvolvedInDysfunction
cancer,kinasesApprovedForTreatmentOfHumanEpidermalGrowthFactorReceptor2-negativeBreastCancerInCombination
Other,effectiveTreatmentOption
Other,coregulators
Other,symptomsAssociated
Other,shorterDisease-freeSurvival
Other,proportionalHazardRegressionAnalysis
Other,personalGoals
Other,curvesAtSamplingRate
imaging,canUsedDuringDevelopmentOfDedicatedBreastCtImagingForOptimizationOfImageAcquisition
Other,fulvestrantInPostmenopausalWomen
Other,leadingCauseOfDeath
Other,prognostic
Other,importantRole
imaging,accuracyForMriEvaluation
Other,eortcQlq-c30
cancer,cyclin-dependentKinasesApprovedForTreatmentOfHormoneReceptor-positiveGrowthFactorReceptor2-negativeBreastCancer
Other,potentialTargetsForTnbc
perfusion,realisticPatient-based4dBreastPhantomIncludingTime-varyingContrastEnhancementForSimulationOfBreastCtPerfusionImaging
antioxidant,antioxidantScavengingAgainstCellLines
Other,haveImplicated
Other,tumorGrowthReductionInEgki-1-treatedMice
Other,continuedPresenceOfS961
Other,nf-Îºb/sox4Activation
cancer,kinasesApprovedForTreatmentOfReceptor-positiveGrowthFactorReceptor2-negativeBreastCancer
Other,impactInMolecularDiagnosticsForTreatmentSelection
Other,managementChallengesInTreatmentOfHrPositive
Other,systems
Other,treatmentOfPost-menopausalOsteoporosis
perfusion,chemotherapyInjectionInInTumorModel
Other,tissueSectionsFollowedByApproach
perfusion,realisticPatient-based4dBreastPhantomIncludingContrastEnhancementForSimulationOfBreastCtPerfusionImaging
Other,withDevelopmentOfSequencingHaveDiscovered
Other,timeToTreatmentFailureInCombination
Other,pathway
Other,older
Other,erÎ±Degradation
Other,wnt/Î²-cateninTranslocation
cancer,evidenceOnPersonalGoal-settingAmongWomenWithBreastCancerDiagnosis
cancer,developmentOfNewGenerationOfTherapiesForAdvancedBreastCancer
Other,PROs
cancer,combinatorialEffectsOnErCancer
cancer,cyclin-dependentKinasesApprovedForTreatmentOfHumanEpidermalGrowthFactorReceptorAdvancedBreastCancer
Other,showHighInvasivenessInMice
cancer,kinasesApprovedForTreatmentOfGrowthFactorReceptorAdvancedBreastCancerInCombination
Other,severalAspectsIncludingCellProliferation
Other,canDeliveredEffectively
Other,likelyEr-driven
Other,expression
Other,cellCycle
prognosis,prognosisDiscussion
Other,investigation
Other,knowledgeOfLateRecurrenceBiology
Other,cyclinDependentKinase
cancer,fewPeptidesDerivedAsVaccineDeliveryModalitiesForTreatmentOfTuboBreastCancerXenograftTumorsOfBalb/cMice
Other,eligibilityCriteria
multicatheter,fractionatedMulticatheterHigh-dose-rateBrachytherapy
Other,breastCt
Other,potentialMechanisms
cancer,cyclin-dependentKinasesApprovedForTreatmentOfHormoneReceptor-positiveGrowthFactorReceptorAdvancedBreastCancerInCombination
Other,rateOfComplicationsInBreastReconstruction
CT,4dBreastCtImageAcquisition
brachytherapy,fractionatedBrachytherapy
Other,dose-dependentManner
Other,haveIntricatelyLinkedToPathogenesis
Other,demonstrated
Other,typicalMorphology
Other,careAllowing
Other,agentForTreatment
Other,135PercecntOfPatients
cancer,prognosisOfBreastCancer
Other,kinasesApprovedForTreatmentInCombinationWithFulvestrantInWomenWithDiseaseProgression
cancer,clinicalOutcomeOfBreastCancerPatientsTreatedWithPalbociclib
cancer,kinasesApprovedForTreatmentOfGrowthFactorReceptor2-negativeBreastCancerInCombination
cancer,kinasesApprovedForTreatmentOfHumanEpidermalGrowthFactorReceptor2-negativeAdvancedBreastCancerInCombination
Other,progressionOfEscc
cancer,kinasesApprovedForTreatmentOfReceptor-positiveHumanEpidermalGrowthFactorReceptor2-negativeAdvancedBreastCancerInCombination
Other,lessToxicity
Other,0.002
Other,EMT
Other,lowRate
Other,highlyExpressed
Other,reprogramming
Other,presenceOfInsulin
Other,canTreatedWithHormonalReplacementTherapies
Other,matchingPatternsSeenOnHistology
Other,voxelInPhantom
irradiation,decline
Other,changesInBreastCosmesis
Other,generallyVeryPoor
Other,demonstratedByUpregulationOfE-cadherinExpressionInLungTissue
Other,surgery
Other,inMultivariableCox'sProportionalHazardsSurvivalModelAssociatedWithHazardRatioOf004
Other,HRs
Other,adjustmentForTumorStage
Other,inTumorModel
Other,breast-cancerCellLines
Other,potentialMechanismsInvolvedInMitochondrialDysfunctionMediatedBySeveralEstrogenReceptorSubtypes
Other,canUsedDuringDevelopment
Other,escalatedTo14Mg/m2ForEriForGem
cancer,cyclin-dependentKinasesApprovedForTreatmentOfReceptor-positiveEpidermalGrowthFactorReceptor2-negativeAdvancedBreastCancerInCombination
Other,evidence
Other,end
Other,firstUsed
Other,c-mycDegradation
cancer,kinasesApprovedForTreatmentOfHumanGrowthFactorReceptorBreastCancer
Other,basal/HER2
Other,currentKnowledge
Other,searchOfDataInAscoProceedings
Other,free-radicalScavengingAgainstHumanBreast-cancerCellLines
pallidus,activitiesOfOPallidus
cancer,breastCancerPathogenesis
antioxidant,antioxidantFree-radicalScavengingAgainstCellLines
Other,epidermal
cancer,combinationTherapyForPatientsWithRecurrentBreastCancerDueToHematologicalToxicities
Other,currentKnowledgeOfLateRecurrenceBiology
cancer,er-positive/humanEpidermalGrowthFactorReceptor2-negativeBreastCancer
Other,conducted
Other,4dBreastPhantomIncludingContrastEnhancementForSimulation
cancer,advancedRecurrentBreastCancer
Other,alendronateRegardingAssociationWithBoneMetastases
cancer,cyclin-dependentKinasesApprovedForTreatmentOfHormoneReceptor-positiveEpidermalGrowthFactorReceptor2-negativeAdvancedBreastCancer
cancer,514WomenWithBreastCancer
Other,couldSufficient
Other,commonAgentForTreatmentOfOsteoporosis
Other,canDeliveredByPractice-basedClinicalTeamWithinPatientEducationAppointment
cancer,combinationTherapyForPatientsWithBreastCancerDueToHematologicalToxicities
Other,significantlyShorterSurvival
Other,lincrna-rorExpression
Other,efficacyInPatientsPretreated
Other,variousMethodsOfFlapFixation
cancer,kinasesApprovedForTreatmentOfEpidermalGrowthFactorReceptorBreastCancer
Other,measureOfCestEffectAt05ÎtSaturationAmplitude
Other,inCox'sProportionalHazardsSurvivalModelAssociatedWithHazardRatioOf004ForBoneMetastasis
Other,potentActivity
Other,cellGrowth
Other,0.01
Other,impactInMolecularDiagnostics
Other,interventionEasy
Other,hormoneReceptorPositive
Other,cyst
Other,backboneInCases
Other,Î¼g/ml
Other,scavenging
cancer,cyclin-dependentKinasesApprovedForTreatmentOfReceptor-positiveHumanGrowthFactorReceptorBreastCancerInCombination
Other,centralSystemMetastasesAmongMalignancies
perfusion,realisticPatient-based4dDigitalBreastPhantomIncludingTime-varyingContrastEnhancementForSimulationOfDedicatedBreastCtPerfusionImaging
Other,mayPotentialTargetInEscc
Other,size
Other,effectsOfEndocrineTherapy
Other,viable
cancer,existingEvidenceOnGoal-settingAmongWomenWithBreastCancerDiagnosis
Other,rateInImmediateBreastReconstruction
Other,aspectsOfMalignantPhenotype
cancer,alsoIncreasinglyConsideredAsCancerVaccineDeliveryStrategy
Other,epithelial-mesenchymalTransitionInMouse
cancer,anti-proliferativeEffectsOnErCancer
perfusion,patient-based4dBreastPhantomIncludingContrastEnhancementForSimulationOfDedicatedBreastCtPerfusionImaging
Other,NMR
Other,prognosticValue
Other,diseaseNature
Other,diagnosedDiseases
Other,yearsOfEndocrineTherapyReduced
Other,cyclin-dependentKinasesApprovedForTreatmentInCombinationWithFulvestrantInPostmenopausalWomenWithDiseaseProgression
Other,epithelialMorphology
Other,TE-10
Other,heterogenic
Other,karyotypeWithStructuralAberrations
Other,development
Other,hasApproved
antioxidant,excellentAntioxidant
Other,womenWithHer2-positiveBcs
Other,90EsccTissueSamples
Other,divided
Other,managementChallengesInTreatmentOfHr
antioxidant,antioxidantScavengingAgainstHumanBreast-cancerCellLines
Other,efficacyInPatients
Other,differencesBetweenTumor
Other,0.447
Other,searchOfData
Other,searchToolForRetrievalOfInteractingGenesDatabase
Other,13c2-dimensionalMagneticResonance
cancer,outcomeOfBreastCancerPatientsTreated
Other,timeToTreatmentFailureAsSecond-lineOfTherapy
cancer,combinatorialAnti-proliferativeEffectsOfTamoxifenOnErCancer
brachytherapy,interstitialFractionatedHigh-dose-rateBrachytherapy
cancer,cyclin-dependentKinasesApprovedForTreatmentOfReceptor-positiveEpidermalGrowthFactorReceptorAdvancedBreastCancerInCombination
Other,14Mg/m2
Other,tissueSections
Other,threeMicroarrayDatasetsDerivedFromGeneExpressionOmnibus
Other,G2
Other,furtherAdjustmentForTumorStage
Other,dose
Other,leadingCauseOfDeathInWomen
Other,effective
Other,MTD
brachytherapy,interstitialHigh-dose-rateBrachytherapy
cancer,cyclin-dependentKinasesApprovedForTreatmentOfReceptor-positiveEpidermalGrowthFactorReceptorBreastCancer
Other,sustainedResponse
perfusion,perfusionInTypes
Other,willRandomlyAllocated
Other,shorterSurvival
Other,clinicalSurveillancePrograms
Other,expressionOfIrs
Other,realisticPatient-based4dDigitalBreastPhantom
Other,scavengingAgainstCellLines
cancer,cancerCellGrowth
Other,haveInconsistent
Other,activities
Other,treatmentOption
Other,adenocarcinomaMetastasisFromUnknownSite
cancer,cyclin-dependentKinasesApprovedForTreatmentOfReceptor-positiveEpidermalGrowthFactorReceptor2-negativeBreastCancerInCombination
Other,immediateImplant-basedBreastReconstruction
ESR1,plasmaEsr1MutationsInMbcPatientsWithPriorExposureToAiTherapy
Other,studies
Other,agent
Other,canUsed
Other,anti-proliferativeEffectsOfTamoxifen
Other,probability
Other,beliefsAboutDiseaseCurability
Other,Embase
Other,severalAspects
Other,retrospective
Other,cyclin-dependentKinasesApprovedForTreatmentInCombinationWithFulvestrantInWomen
Other,outcomes
cancer,usefulForDiagnosisOfCancer
cancer,her2CancerPatients
Other,expressedGenes
cancer,breastCancerMetastasis
Other,kinasesApprovedForTreatmentInCombinationWithFulvestrantInPostmenopausalWomenWithDiseaseProgression
Other,transition
antioxidant,antioxidant
Other,differentiallyExpressedGenes
Other,rateInImplant-basedBreastReconstruction
Other,willAllocated
Other,anti-proliferativeEffects
Other,canDeliveredByPractice-basedClinicalTeamWithinSemi-structuredPatientEducationAppointment
Other,needed
Other,pivotalRoleOfIrAntagonistS961OnIrSignallingInMcf-7
Other,cause
Other,woundHealing
Other,clinicalImpactOfIntratumorHeterogeneity
Other,adenocarcinomaMetastasisFromPrimarySite
Other,treatmentCessation
Other,clinicalImpactOfHeterogeneityOfErProteinExpression
Other,rateOfComplicationsInImplant-basedBreastReconstruction
Other,rnaInterference
Other,0.05
Other,tissueBiopsies
Other,timeToTreatmentFailureInCombinationAsSecond-lineOfTherapy
Other,diffuseAdenocarcinomaMetastasisInBoneMarrow
Other,circulatingTumorDna
Other,component
Other,evenCanTreated
Other,voxelSizeOf273Îm
cancer,potentialOfBreastCancerCells
cancer,kinasesApprovedForTreatmentOfEpidermalGrowthFactorReceptorBreastCancerInCombination
perfusion,realistic4dBreastPhantomIncludingTime-varyingContrastEnhancementForSimulationOfBreastCtPerfusionImaging
Other,near-tetraploidKaryotypeWithAberrations
Other,patient-based4dBreastPhantom
Other,13cMagneticResonance
Other,surgicalMenopause
Other,4dBreastPhantomIncludingTime-varyingContrastEnhancementForSimulation
Other,willRandomlyAllocatedToOneThreeTreatmentArms
Other,free-radicalScavengingAgainstHumanCellLines
Other,potentialMechanismsInvolvedInMitochondrialDysfunction
Other,wechslerMemoryScale-revisedTest
Other,correlationCoefficient
Other,thusMayKeyFactorInProgression
cancer,cancerCells
ESR1,plasmaEsr1MutationsInMbcPatientsWithExposure
Other,evenPresence
imaging,canUsedDuringDevelopmentOfDedicatedBreastCtImagingForOptimization
Other,canUsedForOptimization
cancer,cyclin-dependentKinasesApprovedForTreatmentOfReceptor-positiveEpidermalGrowthFactorReceptorBreastCancerInCombination
Other,expressionInEscc
Other,moreLikely
Other,usefulForEarlyDiagnosis
cancer,2231MrnaProfilesOfPatientsWithEr-positive/humanGrowthFactorReceptorBreastCancer
Other,presence
Other,loopTams
Other,risk
Other,progressionSurvival
Other,related
cancer,kinasesApprovedForTreatmentOfHormoneReceptor-positiveHumanGrowthFactorReceptor2-negativeAdvancedBreastCancer
cancer,kinasesApprovedForTreatmentOfReceptor-positiveHumanGrowthFactorReceptor2-negativeAdvancedBreastCancerInCombination
cancer,cyclin-dependentKinasesApprovedForTreatmentOfEpidermalGrowthFactorReceptorBreastCancerInCombination
Other,developmentOfTherapies
Other,above-mentionedMethods
Other,PubMed
Other,backbone
Other,higher
Other,outcomeOfEsccPatients
Other,canUsedDuringDevelopmentForOptimization
Other,therapy
Other,sexualFunctionOfWomen
perfusion,perfusionInDifferentTypesOfBreastLesions
Other,combinationWithEndocrineTherapy
Other,3
cancer,unfavorablePrognosisOfBreastCancer
Other,PFS
multicatheter,interstitialFractionatedMulticatheterBrachytherapy
Other,worsePfs
Other,identified
Other,combinationWithLetrozole
cancer,clinicalOutcomeOfBreastCancerPatients
Other,colonyFormation
Other,repressedByTamAfterSilencingLincrna-ror
Other,mightTherapeuticEffectForPatients
Other,aspects
cancer,cyclin-dependentKinasesApprovedForTreatmentOfHormoneReceptor-positiveHumanGrowthFactorReceptorBreastCancerInCombination
Other,furthermoreMayPotentialTherapeuticTarget
cancer,cyclin-dependentKinasesApprovedForTreatmentOfHormoneReceptor-positiveEpidermalGrowthFactorReceptor2-negativeBreastCancer
Other,12PercecntTo265Percecnt
irradiation,breastIrradiation
Other,creation
Other,atEndG1In511PercecntOfPatients
Other,616Percecnt
Other,pivotalRoleOnIrSignalling
Other,realistic4dDigitalBreastPhantomIncludingTime-varyingContrastEnhancement
Other,trainees
cancer,cyclin-dependentKinasesApprovedForTreatmentOfEpidermalGrowthFactorReceptorAdvancedBreastCancerInCombination
Other,6SubtypesWithDistinctSignaturesWithDifferentPrognoses
Other,molecularPathwaysInvolvedInPathogenesis
Other,commonComplication
cancer,novelStrategyForBreastCancerMetastasisPrevention
Other,Database
cancer,cyclin-dependentKinasesApprovedForTreatmentOfHormoneReceptor-positiveEpidermalGrowthFactorReceptorAdvancedBreastCancer
Other,theirAssociation
Other,6SubtypesWithMolecularSignaturesWithDifferentPrognoses
Other,patientsWithTumorsShowing
Other,patient-based4dDigitalBreastPhantom
cancer,kinasesApprovedForTreatmentOfReceptor-positiveHumanGrowthFactorReceptor2-negativeAdvancedBreastCancer
imaging,canUsedDuringDevelopmentOfContrast-enhancedBreastCtImaging
Other,4dDigitalBreastPhantomIncludingContrastEnhancementForSimulation
Other,realistic4dBreastPhantomIncludingTime-varyingContrastEnhancementForSimulation
Other,possibleInfluenceOnPatient-reportedOutcomes
Other,cellularProliferationInBreastTumourCells
Other,transitionToS-phase
Other,tolerabilityOfCombinationTherapy
Other,stillRequired
Other,changes
cancer,patientsWithAdvancedBreastCancer
Other,roleOfIrAntagonistS961
Other,threeMicroarrayDatasetsDerived
cancer,clinicalOutcomeOfHr-positiveBreastCancerPatients
Other,firstYearsAfterDiagnosis
Other,lateRecurrenceFromTreatmentExtension
Other,realisticPatient-based4dBreastPhantom
Other,inMultivariableCox'sProportionalHazardsSurvivalModelAssociatedWithHazardRatioForBoneMetastasis
perfusion,4dDigitalBreastPhantomIncludingContrastEnhancementForSimulationOfBreastCtPerfusionImaging
Other,lateRecurrences
Other,12Percecnt
cancer,outcomeOfHr-positiveBreastCancerPatientsTreatedWithPalbociclib
Other,significantlyDownregulated
Other,alendronateRegardingAssociation
Other,canDeliveredEffectivelyByPractice-basedTeam
Other,alsoIncreasinglyConsidered
Other,existingEvidenceOnPersonalGoal-setting
Other,haveDescribed
Other,anti-estrogenTherapy
Other,highRecurrenceRisk
Other,thusMayKeyFactor
cancer,kinasesApprovedForTreatmentOfReceptor-positiveEpidermalGrowthFactorReceptorAdvancedBreastCancerInCombination
cancer,cyclin-dependentKinasesApprovedForTreatmentOfReceptor-positiveHumanGrowthFactorReceptorAdvancedBreastCancer
Other,whereMajorComponentOfStudy
Other,seen
Other,adenocarcinomaMetastasisInBoneMarrow
Other,searchToolForRetrieval
Other,functionalInformation
Other,willAllocatedToOneOfThreeTreatmentArmsConsistingOfFlapFixation
Other,study
Other,lowRateOfComplicationsInImplant-basedBreastReconstruction
Other,potentialMechanismsInvolvedInDysfunctionMediated
Other,required
cancer,anti-proliferativeEffectsOfTamoxifenOnErCancer
Other,howeverStillRequired
brachytherapy,fractionatedHigh-dose-rateBrachytherapy
cancer,degreeOfConcernAboutOvarianCancerRisk
cancer,fewPeptidesDerivedFromHer2/neuProto-oncogeneAsVaccineDeliveryModalitiesForTreatmentOfTuboBreastCancerXenograftTumors
Other,canDeliveredByClinicalTeam
Other,presentedByFusionsToPhageCoatProteins
cancer,2231MrnaProfilesOfPatientsWithEr-positive/humanGrowthFactorReceptor2-negativeBreastCancer
Other,applied
Other,timeToTreatmentFailureInCombinationWithLetrozoleAsSecond-lineOfTherapy
Other,915PercecntOfResponders
Other,significantlyCorrelated
Other,506Percecnt
Other,transcriptionPolymeraseChainReaction
Other,functionOfWomen
Other,interestingStrategy
Other,mainTreatment
Other,dysfunctionalExcitement
Other,disease-freeSurvival
Other,willAllocatedToOneThreeTreatmentArms
Other,searchOfDataOnPalbociclibInFdaWebsite
Other,poorOutcomes
Other,combinationTherapyForPatients
Other,haveIdentified
Other,novelUtilizationOf3-o-p-coumaroyltormenticAcid
ESR1,plasmaEsr1MutationsInMbcPatientsWithExposureToAiTherapy
Other,13c2-dimensionalNuclearMagneticResonance
Other,5YearsOfTamoxifenTherapyWith5YearsOfTamoxifen
Other,impactOfHeterogeneityInMolecularDiagnosticsForTreatmentSelection
Other,ALDH
Other,expectedEnhancementOfTissuesConsistent
Other,morphologicalChanges
Other,thenDetectedBy3
Other,combinedHazardRatios
Other,4dBreastPhantomIncludingContrastEnhancement
cancer,greatPromiseInFutureOfCancerImmunotherapy
Other,functionalInformationOfBreast
Other,90PercecntOfCases
Other,canDeliveredEffectivelyByPractice-basedClinicalTeamWithinSemi-structuredPatientEducationAppointment
cancer,impactForTreatmentSelectionInHer2CancerPatients
Other,phase
cancer,cyclin-dependentKinasesApprovedForTreatmentOfReceptor-positiveHumanGrowthFactorReceptor2-negativeBreastCancerInCombination
Other,impactInDiagnostics
cancer,kinasesApprovedForTreatmentOfReceptor-positiveEpidermalGrowthFactorReceptor2-negativeBreastCancerInCombination
Other,TAMs
Other,delayedWoundHealing
cancer,existingEvidenceOnPersonalGoal-settingAmongWomenWithBreastCancerDiagnosis
Other,termSurvivalDataAreLacking
Other,ovTherapyWithCheckpointInhibitors
Other,upregulationOfE-cadherinExpressionInBiopsiedLungTissue
prognosis,prognosisEspecially
Other,immunofluorescence
Other,dimensions
Other,resultFromAdenocarcinomaMetastasisInBoneMarrowFromSite
perfusion,perfusionParametersForTissue
Other,2231MrnaProfilesOfPatients
Other,recurrenceRisk
Other,deathInWomen
Other,resultFromDiffuseAdenocarcinomaMetastasisInBoneMarrowFromSite
cancer,breastCancerPatients
Other,cellGrowthOfMcf-7CellsAtHigherConcentrations
Other,differentiation
Other,womenWithHer2-positiveBcsTreatedWithTrastuzumabFrom2008To2017
Other,clinicalOutcome
Other,forPrimaryOutcome63Months
multicatheter,interstitialMulticatheterBrachytherapy
Other,mayKeyFactor
Other,511Percecnt
cancer,cyclin-dependentKinasesApprovedForTreatmentOfHormoneReceptor-positiveHumanGrowthFactorReceptorAdvancedBreastCancer
cancer,threeRepresentationsOfBreastCancerPatientCohorts
Other,differentPrognoses
Other,similar
CT,breastCtImage
Other,adenocarcinomaMetastasisFromUnknownPrimarySite
Other,continuousTime-enhancementCurves
Other,searchInFdaWebsite
Other,systemMetastases
antioxidant,antioxidantFree-radicalScavenging
Other,resultFromAdenocarcinomaMetastasisInBoneMarrowFromUnknownPrimarySite
Other,survivalOfLife
Other,inactivationOfEpidermalGrowthFactorReceptorSignalingPathway
Other,significantTumorGrowthReductionInEgki-1-treatedMice
Other,commonAgentForTreatmentOfPost-menopausalOsteoporosis
Other,presenceOfS961
Other,selectiveEstrogenReceptorModulators
cancer,kinasesApprovedForTreatmentOfHormoneReceptor-positiveHumanGrowthFactorReceptor2-negativeBreastCancer
Other,files
Other,surveillance
Other,withDevelopmentHaveDiscovered
Other,longTermSurvivalDataAreLacking
Other,continuousTime-enhancementCurvesAtSamplingRate
cancer,kinasesApprovedForTreatmentOfEpidermalGrowthFactorReceptor2-negativeBreastCancerInCombination
Other,investigated
perfusion,4dBreastPhantomIncludingTime-varyingContrastEnhancementForSimulationOfBreastCtPerfusionImaging
Other,opaeConcentrationUpTo240G/ml
Other,scarce
cancer,breastCancerCellProliferation
Other,haveIntricatelyLinkedToPathogenesisOfBreastCarcinoma
cancer,cyclin-dependentKinasesApprovedForTreatmentOfHormoneReceptor-positiveHumanGrowthFactorReceptor2-negativeBreastCancerInCombination
cancer,progressionOfBreastCancer
Other,highestLincrna-rorExpression
Other,mayKeyFactorInProgression
cancer,cyclin-dependentKinasesApprovedForTreatmentOfEpidermalGrowthFactorReceptor2-negativeBreastCancer
Other,breast-conservingSurgery
Other,itsSequelae
Other,crucial
Other,thenDetected
Other,symptomsAssociatedWithSurgicalMenopause
imaging,canUsedDuringDevelopmentOfDynamicContrast-enhancedBreastCtImagingForOptimizationOfImageAcquisition
Other,poorOutcomeOfEsccPatients
Other,characterized
multicatheter,fractionatedMulticatheterBrachytherapy
cancer,strategyForBreastCancerMetastasisPrevention
biomarkers,potentialBiomarkers
Other,promiseInFuture
Other,haveIntricatelyLinked
Other,cox'sProportionalHazardsSurvivalModel
Other,implant-basedImmediateBreastReconstruction
Other,existingEvidenceOnPersonalGoal-settingAmongWomen
Other,severalAspectsOfMalignantPhenotype
perfusion,realisticPatient-based4dBreastPhantomIncludingContrastEnhancementForSimulationOfDedicatedBreastCtPerfusionImaging
cancer,usefulForDiagnosisOfBreast/ovarianCancer
Other,4dDigitalBreastPhantomIncludingTime-varyingContrastEnhancementForSimulation
cancer,kinasesApprovedForTreatmentOfHormoneReceptor-positiveEpidermalGrowthFactorReceptorAdvancedBreastCancer
Other,combinationTherapyForPatientsDueToToxicities
cancer,patientsWithAdvancedBreastCancerAsValuable
Other,mostCommonOralAgent
cancer,kinasesApprovedForTreatmentOfReceptor-positiveEpidermalGrowthFactorReceptor2-negativeAdvancedBreastCancer
Other,association
Other,mightTherapeuticEffectForPatientsLikeOurs
Other,71PercecntForPinchTest
cancer,breastCancerLymphNodeMetastasis
cancer,kinasesApprovedForTreatmentOfHormoneReceptor-positiveHumanGrowthFactorReceptorAdvancedBreastCancer
Other,mightEffectForPatientsLikeOurs
Other,fewPeptidesDerivedFromHer2/neuProto-oncogeneAsVaccineDeliveryModalitiesForTreatment
Other,efficacyOfPalbociclib
Other,potentialMechanismsInvolved
Other,intensiveSurveillancePrograms
Other,hasLinkedWithTumorSurvivalOfBrain
Other,questionnaire
Other,degreeOfConcern
Other,rightBreasttreatment
Other,likelihoodOfBoneMetastases
Other,searchInFdaWebsiteInAscoProceedings
Other,distinctAntagonism
Other,recombinantGh
Other,breast.Treatment
Other,willRandomlyAllocatedToOneOfThreeTreatmentArmsConsistingOfFlapFixation
Other,finallyCanSimulated
Other,evaluated
Other,atEndOfRtTreatmentG1In511Percecnt
Other,timeToTreatmentFailureInCombinationWithLetrozoleAsSecond-line
Other,valueOfHubGenes
Other,scavengingAgainstBreast-cancerCellLines
cancer,cyclin-dependentKinasesApprovedForTreatmentOfHumanGrowthFactorReceptor2-negativeBreastCancerInCombination
antioxidant,antioxidantAgainstCellLines
Other,cxcl1Administration
cancer,newModalitiesInCancerTherapeutics
cancer,frequentlyOccurringCancer
Other,irOverexpression
Other,915Percecnt
cancer,cyclin-dependentKinasesApprovedForTreatmentOfReceptor-positiveEpidermalGrowthFactorReceptor2-negativeBreastCancer
Other,highestGene
cancer,cyclin-dependentKinasesApprovedForTreatmentOfHumanGrowthFactorReceptorAdvancedBreastCancer
perfusion,realistic4dBreastPhantomIncludingContrastEnhancementForSimulationOfBreastCtPerfusionImaging
Other,correlated
Other,strategy
Other,novelStrategy
Other,currentKnowledgeOfRecurrenceBiology
cancer,kinasesApprovedForTreatmentOfReceptor-positiveHumanGrowthFactorReceptor2-negativeBreastCancer
Other,structuralAberrations
Other,13c2-dimensionalResonance
Other,hazardRatio
pallidus,anticancerActivitiesOfOPallidus
cancer,alsoIncreasinglyConsideredAsNewCancerVaccineDeliveryStrategy
cancer,japanesePatientsWithMetastaticBreastCancer
Other,impactOfIntratumorHeterogeneityForTreatmentSelection
Other,combinationWithFulvestrant
cancer,cyclin-dependentKinasesApprovedForTreatmentOfEpidermalGrowthFactorReceptorAdvancedBreastCancer
Other,womenWithBcsTreatedWithTrastuzumab
Other,major
Other,intraoperativeFindings
Other,near-tetraploidKaryotype
Other,diffuseAdenocarcinomaMetastasisFromPrimarySite
Other,realistic4dBreastPhantomIncludingContrastEnhancement
Other,canDeliveredByTeamWithinSemi-structuredPatientEducationAppointment
Other,peptidesDerivedFromHer2/neuProto-oncogeneAsVaccineDeliveryModalitiesForTreatment
Other,sideEffects
cancer,alsoConsideredAsCancerVaccineDeliveryStrategy
Other,expressed
Other,colonization
Other,increasingOpaeConcentration
cancer,kinasesApprovedForTreatmentOfHumanGrowthFactorReceptor2-negativeAdvancedBreastCancer
cancer,combinationTherapyForPatientsWithAdvancedRecurrentBreastCancerDueToHematologicalToxicities
Other,mostCommonAgent
cancer,impactOfHeterogeneityInMolecularDiagnosticsForTreatmentSelectionInHer2CancerPatients
Other,boneMarrowAdiposeTissueNiche
Other,expressionOfMitochondrialApoptoticProteins
Other,those
Other,nonstandardizedPhotographs
Other,support
Other,tnbcPatients
Other,manner
perfusion,breastTissuePerfusion
Other,breastConservationTherapy
Other,inCox'sHazardsSurvivalModelAssociatedWithHazardRatioForBoneMetastasis
Other,0.630
Other,usuallyWell-accepted
cancer,cyclin-dependentKinasesApprovedForTreatmentOfEpidermalGrowthFactorReceptor2-negativeBreastCancerInCombination
imaging,90PercecntAccuracyForMriPreoperativeEvaluation
Other,females
cancer,kinasesApprovedForTreatmentOfEpidermalGrowthFactorReceptorAdvancedBreastCancer
cancer,kinasesApprovedForTreatmentOfHumanGrowthFactorReceptor2-negativeAdvancedBreastCancerInCombination
Other,epithelial-mesenchymalTransition
Other,haveLinked
brachytherapy,possibleInfluenceOfBrachytherapy
cancer,patientsWithBreastCancerAsValuable
Other,key
antioxidant,antioxidantFree-radicalScavengingAgainstBreast-cancerCellLines
Other,haveDisappointing
Other,whereMajorComponent
Other,motilityPotential
Other,adjustment
Other,PCR
Other,tumorGrowthReduction
Other,vasculature
Other,lowRateInImmediateBreastReconstruction
Other,estrogenReceptor
Other,87Percecnt
Other,lowerDegree
Other,significantlyWorsePfs
Other,antagonism
imaging,canUsedDuringDevelopmentOfContrast-enhancedBreastCtImagingForOptimization
Other,inMultivariableCox'sHazardsSurvivalModelAssociatedWithHazardRatio
Other,theirAssociationWithEarlyRecurrenceRisk
Other,expressionOfProteins
Other,willRandomlyAllocatedToOneOfThreeTreatmentArmsConsisting
Other,centralSystemMetastasesAmongSevereMalignancies
Other,estradiolHormone
Other,measureOfCestEffect
Other,tumorsShowing
Other,haveDiscoveredInTissues
Other,pooledAnalysis
Other,2014
Other,lowerLikelihoodOfBoneMetastasesInWomen
Other,importantGrowthPathway
cancer,cyclin-dependentKinasesApprovedForTreatmentOfReceptor-positiveHumanGrowthFactorReceptor2-negativeAdvancedBreastCancerInCombination
brachytherapy,possibleInfluenceOfBrachytherapyOnOutcomes
cancer,cyclin-dependentKinasesApprovedForTreatmentOfHormoneReceptor-positiveEpidermalGrowthFactorReceptorBreastCancer
Other,typicalEpithelialMorphology
Other,safe
Other,balb/cNudeMice
Other,nervousSystemMetastases
Other,combinatorialAnti-proliferativeEffectsOfTamoxifen
Other,potentialMechanismsInvolvedInMitochondrialDysfunctionMediatedByEstrogenReceptorSubtypes
cancer,cyclin-dependentKinasesApprovedForTreatmentOfHormoneReceptor-positiveEpidermalGrowthFactorReceptor2-negativeBreastCancerInCombination
Other,it
Other,maintainedInVitro
Other,closedLoopStructure
Other,prophylacticBreast
Other,gene
Other,boost
Other,tissueGlues
Other,lowRateOfComplicationsInImmediateBreastReconstruction
Other,oncologyDivisionAtTelAvivMedicalCenter
Other,withDevelopmentOfSequencingHaveDiscoveredInTissues
Other,ascoProceedings
Other,impactOfIntratumorHeterogeneityOfErProteinExpression
Other,showHighInvasiveness
Other,result
perfusion,4dBreastPhantomIncludingContrastEnhancementForSimulationOfBreastCtPerfusionImaging
Other,lowerLikelihood
Other,hazardRatioOf004ForBoneMetastasis
Other,prognosticForRecurrence
Other,applications
perfusion,perfusion
Other,genesBetweenTnbc
Other,used
Other,erPatients
Other,reverseTranscriptionPolymeraseChainReaction
Other,responsiveGene
Other,boneMarrowMicroenvironment
Other,her2-positiveBcsTreatedFrom2008To2017
Other,canAlsoSimulated
Other,diffuseAdenocarcinomaMetastasisFromUnknownPrimarySite
cancer,peptidesDerivedFromHer2/neuProto-oncogeneAsVaccineDeliveryModalitiesForTreatmentOfTuboBreastCancerXenograftTumors
Other,determined
Other,13cNuclearResonance
cancer,kinasesApprovedForTreatmentOfReceptor-positiveEpidermalGrowthFactorReceptorBreastCancer
Other,seromaFormationInMethodsOfFlapFixation
Other,expectedEnhancementOfTissuesConsistentWithInputParameters
Other,CIs
Other,Â¹H
Other,causeOfDeathInWomen
Other,cellGrowthAtHigherConcentrations
cancer,likelihoodOfBoneMetastasesInWomenWithBreastCancer
Other,willSearched
Other,multivariableCox'sHazardsSurvivalModel
Other,canDeliveredEffectivelyByClinicalTeam
cancer,kinasesApprovedForTreatmentOfEpidermalGrowthFactorReceptor2-negativeAdvancedBreastCancer
Other,determine
Other,haveShown
Other,timeToTreatmentFailureOfPalbociclibInCombinationWithLetrozole
Other,recurrenceRiskBeyond5Years
Other,knowledgeOnHumanCircrnas
Other,realistic4dDigitalBreastPhantomIncludingTime-varyingContrastEnhancementForSimulation
Other,expressionOfGenes
Other,invasionAbility
Other,databaseForAnnotation
Other,epithelialMarkerProteinsLikeOccludin
Other,likelihoodOfBoneMetastasesInPostmenopausalWomen
Other,accuracy
cancer,haveImplicatedInPromotionOfBreastCancerGrowth
Other,13cResonance
cancer,utilizationOfAcidForBreastCancerTherapy
Other,level1
cancer,kinasesApprovedForTreatmentOfReceptor-positiveHumanGrowthFactorReceptorBreastCancerInCombination
Other,resultFromDiffuseAdenocarcinomaMetastasisInBoneMarrowFromUnknownPrimarySite
Other,furthermoreMayPotentialTarget
cancer,kinasesApprovedForTreatmentOfHormoneReceptor-positiveHumanGrowthFactorReceptor2-negativeAdvancedBreastCancerInCombination
Other,theirSexualRelations
cancer,cyclin-dependentKinasesApprovedForTreatmentOfEpidermalGrowthFactorReceptor2-negativeAdvancedBreastCancer
cancer,impactOfHeterogeneityInDiagnosticsForTreatmentSelectionInHer2CancerPatients
cancer,kinasesApprovedForTreatmentOfHormoneReceptor-positiveHumanGrowthFactorReceptor2-negativeBreastCancerInCombination
cancer,cyclin-dependentKinasesApprovedForTreatmentOfHormoneReceptor-positiveEpidermalGrowthFactorReceptorBreastCancerInCombination
Other,impactOfIntratumorHeterogeneityInMolecularDiagnostics
Other,highExpressionOfEstrogen-responsiveGenes
Other,lowRateInImplant-basedBreastReconstruction
Other,adjuvantTreatment
Other,cyclin-dependentKinasesApproved
Other,existingEvidenceOnGoal-settingAmongWomen
Other,study2
cancer,kinasesApprovedForTreatmentOfHormoneReceptor-positiveEpidermalGrowthFactorReceptorAdvancedBreastCancerInCombination
Other,canTreated
Other,prognosticForLateRecurrence
perfusion,realistic4dDigitalBreastPhantomIncludingContrastEnhancementForSimulationOfBreastCtPerfusionImaging
Other,commonOralAgentForTreatmentOfOsteoporosis
Other,favorableBoneMarrowMicroenvironment
Other,doubleBlindRandomizedControlledTrial
Other,vaccine
Other,expressionOfTdo2InEscc
Other,commonOralAgentForTreatment
Other,combinationTherapyForPatientsDue
Other,pearson'sCorrelationCoefficient
Other,realistic4dDigitalBreastPhantomIncludingContrastEnhancementForSimulation
cancer,kinasesApprovedForTreatmentOfHumanGrowthFactorReceptorAdvancedBreastCancer
Other,seromaFormationInMethods
irradiation,acceleratedPartialBreastIrradiation
Other,continuousCurvesAtSamplingRate
Other,furtherInvestigationInFutureStudies
Other,cellPopulation
imaging,canUsedDuringDevelopmentOfDynamicBreastCtImaging
Other,newParadigm
cancer,kinasesApprovedForTreatmentOfEpidermalGrowthFactorReceptor2-negativeBreastCancer
Other,64Months
cancer,lowerLikelihoodOfBoneMetastasesInWomenWithEarlyBreastCancer
Other,timeToTreatmentFailureOfPalbociclibInCombination
Other,impactOfHeterogeneityInDiagnosticsForTreatmentSelection
Other,sampling
Other,higherProbabilityOfRelapse
Other,generallyPoor
Other,laboratory
Other,investigationInFutureStudies
Other,13cNuclearMagneticResonance
Other,benefit
cancer,cyclin-dependentKinasesApprovedForTreatmentOfReceptor-positiveHumanGrowthFactorReceptorAdvancedBreastCancerInCombination
Other,extendedEndocrineTherapy
Other,canModified
Other,patientsWithHormoneReceptorPositive
perfusion,patient-based4dDigitalBreastPhantomIncludingTime-varyingContrastEnhancementForSimulationOfDedicatedBreastCtPerfusionImaging
Other,onlineKaplan-meierPlotterSurvivalAnalysisTool
Other,breastCarcinomaCells
Other,07Percecnt
perfusion,realisticPatient-based4dBreastPhantomIncludingTime-varyingContrastEnhancementForSimulationOfDedicatedBreastCtPerfusionImaging
Other,diffuseAdenocarcinomaMetastasisFromUnknownSite
Other,potentialPredictiveBiomarker
Other,reduction
Other,4dDigitalBreastPhantomIncludingTime-varyingContrastEnhancement
Other,publishedFemales
Other,phytochemicals
Other,enhancementOfTissuesConsistentWithInputParameters
biomarkers,potentialBiomarkersOfResistance
Other,breast
Other,prognosticSignificance
Other,appointment
Other,epithelialMarkerProteins
cancer,kinasesApprovedForTreatmentOfHormoneReceptor-positiveHumanGrowthFactorReceptorBreastCancer
cancer,combinatorialAnti-proliferativeEffectsOnErCancer
Other,combinationTherapyDueToHematologicalToxicities
Other,t-patAppointment
Other,potentialBiomarkerForCdk4/6Inhibitors
cancer,cyclin-dependentKinasesApprovedForTreatmentOfEpidermalGrowthFactorReceptorBreastCancer
Other,anti-cancerTherapeutic
cancer,modalitiesInCancerTherapeutics
Other,howeverStillScarce
Other,tolerabilityOfCombinationTherapyWithEri
Other,fibroglandularTissue
cancer,kinasesApprovedForTreatmentOfHormoneReceptor-positiveEpidermalGrowthFactorReceptorBreastCancer
Other,resultFromDiffuseAdenocarcinomaMetastasisInBoneMarrowFromUnknownSite
Other,haveDisappointingDue
Other,developmentOfPotentTherapies
Other,centralNervousSystemMetastasesAmongMalignancies
Other,otherCases
Other,tamoxifenResistanceOfBcCells
Other,threeMetrics
Other,ongoing
Other,resistant
Other,inMultivariableCox'sHazardsSurvivalModelAssociatedWithHazardRatioOf004ForBoneMetastasis
Other,realisticBeliefsAboutDiseaseCurability
Other,6Subtypes
imaging,canUsedDuringDevelopmentOfBreastCtImagingForOptimizationOfImageAcquisition
Other,womenWorldwide
Other,timeToTreatmentFailureOfPalbociclib
cancer,impactOfIntratumorHeterogeneityForTreatmentSelectionInHer2CancerPatients
imaging,canUsedDuringDevelopmentOfDedicatedBreastCtImaging
Other,firstLineSettings
Other,inCox'sProportionalHazardsSurvivalModelAssociatedWithHazardRatio
Other,4dDigitalBreastPhantomIncludingContrastEnhancement
irradiation,associationOfChemotherapy
cancer,postmenopausalWomenWithEarlyBreastCancer
Other,time
cancer,lowerLikelihoodOfBoneMetastasesInPostmenopausalWomenWithBreastCancer
Other,terms
Other,highestResponsiveGene
Other,cell-deathHistopathology
cancer,cyclin-dependentKinasesApprovedForTreatmentOfReceptor-positiveHumanGrowthFactorReceptor2-negativeAdvancedBreastCancer
Other,OBCS
Other,enhancementOfTissues
Other,recurrencesOccurring
Other,diseases
Other,drivers
Other,clinicalImpact
Other,literature
Other,rateOfComplicationsInImmediateBreastReconstruction
brachytherapy,high-dose-rateBrachytherapy
Other,recurrenceFromTreatmentExtension
cancer,degreeOfConcernAboutCancerRisk
Other,severalAspectsOfPhenotypeIncludingCellProliferation
cancer,hrPositiveMetastaticBreastCancer
Other,cyclin-dependentKinasesApprovedForTreatmentInCombinationWithFulvestrantInWomenWithDiseaseProgressionFollowingEndocrineTherapy
Other,popular
Other,enhancementOfTissuesConsistent
Other,ourLaboratory
Other,inactivation
cancer,utilizationForBreastCancerTherapy
Other,numberOfSeromaAspirationsConsist
imaging,canUsedDuringDevelopmentOfDynamicBreastCtImagingForOptimization
Other,fewPeptidesDerivedAsVaccineDeliveryModalities
cancer,protectiveVaccineAgainstCancer
cancer,outcomeOfBreastCancerPatientsTreatedWithPalbociclib
antioxidant,antioxidantAgainstBreast-cancerCellLines
Other,hydatidCystLocalized
Other,willReported
Other,value
Other,healthyPatientIntoSkin
cancer,cyclin-dependentKinasesApprovedForTreatmentOfHumanGrowthFactorReceptor2-negativeBreastCancer
cancer,kinasesApprovedForTreatmentOfReceptor-positiveEpidermalGrowthFactorReceptor2-negativeAdvancedBreastCancerInCombination
Other,canDeliveredByPractice-basedTeam
Other,quality
imaging,7TMri
Other,fewPeptidesDerived
Other,canDeliveredEffectivelyByTeamWithinSemi-structuredPatientEducationAppointment
Other,endocrineTherapyResistance
Other,numberOfSeromaAspirationsConsistOfNumberOfPatientClinicVisits
Other,resultFromDiffuseAdenocarcinomaMetastasisInBoneMarrowFromPrimarySite
cancer,kinasesApprovedForTreatmentOfReceptor-positiveHumanGrowthFactorReceptorAdvancedBreastCancer
Other,0.009
Other,model
Other,proliferationInBreastTumourCells
Other,furtherAdjustment
cancer,thusMayKeyFactorInProgressionOfBreastCancer
Other,urgentlyNeeded
Other,oncosphereOfCanineTapewormEchinococcusGranulosus
antioxidant,excellentAntioxidantAgainstBreast-cancerCellLines
Other,known
cancer,peptidesDerivedFromHer2/neuProto-oncogeneAsVaccineDeliveryModalitiesForTreatmentOfTuboBreastCancerXenograftTumorsOfBalb/cMice
Other,number
Other,growthPathway
Other,higherExpression
Other,inPhageDisplayImmunotherapyPresentedByFusionsToPhageCoatProteins
Other,resultFromAdenocarcinomaMetastasisInBoneMarrowFromUnknownSite
cancer,cyclin-dependentKinasesApprovedForTreatmentOfHumanGrowthFactorReceptorAdvancedBreastCancerInCombination
imaging,90PercecntAccuracyForMriEvaluation
Other,haveDisappointingDueToModestEffectSizes
Other,howeverRequired
Other,lincrna-rorSilencing
Other,significantDifferences
Other,update
Other,continuousCurvesAtDesiredSamplingRate
Other,phaseIiTrial
Other,detection
Other,totalDose
Other,significantTumorGrowthReductionInMice
cancer,kinasesApprovedForTreatmentOfReceptor-positiveEpidermalGrowthFactorReceptorAdvancedBreastCancer
Other,taken
cancer,fewPeptidesDerivedFromHer2/neuProto-oncogeneAsVaccineDeliveryModalitiesForTreatmentOfTuboBreastCancerXenograftTumorsOfBalb/cMice
ESR1,plasmaEsr1Mutations
cancer,kinasesApprovedForTreatmentOfHormoneReceptor-positiveHumanGrowthFactorReceptorBreastCancerInCombination
perfusion,perfusionParameters
cancer,cyclin-dependentKinasesApprovedForTreatmentOfHormoneReceptor-positiveHumanGrowthFactorReceptor2-negativeAdvancedBreastCancerInCombination
cancer,threeVisualRepresentationsOfBreastCancerPatientCohorts
Other,vmat-sibTechnique
cancer,combinationTherapyForPatientsWithAdvancedBreastCancerDueToHematologicalToxicities
Other,context
Other,that
Other,95PercecntCis
Other,womenWithBcsTreated
Other,sensitivity
imaging,canUsedDuringDevelopmentOfContrast-enhancedDedicatedBreastCtImagingForOptimizationOfImageAcquisition
Other,progressionFreeSurvival
Other,plasmaIl-6Levels
irradiation,adjuvantAcceleratedBreastIrradiation
Other,poorClinicalOutcome
Other,distancesBetweenAnatomicFeatures
Other,continuousTime-enhancementCurvesAtDesiredSamplingRate
Other,cellGrowthOfMcf-7Cells
imaging,canUsedDuringDevelopmentOfDynamicContrast-enhancedDedicatedBreastCtImaging
Other,haveDisappointingDueToEffectSizes
Other,haveDiscoveredInTumorousTissues
Other,tissueSectionsFollowed
Other,resultFromAdenocarcinomaMetastasisInBoneMarrowFromPrimarySite
Other,5Years
cancer,novelUtilizationOfAcidForBreastCancerTherapy
Other,athymicNudeMouseXenograftModel
Other,tissue
cancer,subtypeOfBreastCancerWithClinicalOutcome
Other,priorExposureToAiTherapy
Other,managementChallengesInTreatmentOfAdvancedHr
Other,searchOfDataOnPalbociclibInPubmedInFdaWebsite
Other,penetrationPain
Other,pathwaysInvolvedInPathogenesis
cancer,novelUtilizationForBreastCancerTherapy
Other,DEGs
Other,repressed
Other,haveLinkedToPathogenesisOfBreastCarcinoma
cancer,cyclin-dependentKinasesApprovedForTreatmentOfHumanGrowthFactorReceptor2-negativeAdvancedBreastCancer
cancer,kinasesApprovedForTreatmentOfHumanGrowthFactorReceptor2-negativeBreastCancerInCombination
cancer,womenWithBreastCancer
Other,twoRadiationOncologyCenters
Other,transcriptionOfCellCycleRegulationProteins
Other,intervention
cancer,likelihoodOfBoneMetastasesInPostmenopausalWomenWithEarlyBreastCancer
Other,common
Other,viableEffectiveTreatmentOption
Other,transitionInMouse
Other,cystLocalizedToLiver
cancer,cyclin-dependentKinasesApprovedForTreatmentOfHumanGrowthFactorReceptor2-negativeAdvancedBreastCancerInCombination
Other,only1PatientOfLevel1Group
Other,roleOnIrSignallingInMcf-7
Other,shown
cancer,kinasesApprovedForTreatmentOfHumanGrowthFactorReceptorBreastCancerInCombination
ESR1,plasmaEsr1MutationsInMbcPatientsWithPriorExposure
Other,furtherEndocrineTherapyChoice
Other,ovarianSurgery
Other,realistic4dBreastPhantomIncludingTime-varyingContrastEnhancement
cancer,kinasesApprovedForTreatmentOfHumanGrowthFactorReceptor2-negativeBreastCancer
Other,adenocarcinomaMetastasisFromSite
Other,keyDriversOfProliferation
Other,oncosphereOfTapewormEchinococcusGranulosus
Other,paradigm
imaging,87PercecntForUltrasound
Other,81Percecnt
Other,sideEffectsOfTherapy
Other,symptomsAssociatedWithMenopause
Other,roleOfIrAntagonistS961OnIrSignalling
Other,molecularPathways
Other,existingEvidenceOnGoal-setting
Other,conclusion
Other,highRecurrenceRiskBeyond5Years
Other,downregulated
Other,recurrences
Other,hasLinked
Other,13c2-dimensionalNuclearResonance
Other,modalities
Other,searchOfDataOnPalbociclibInFdaWebsiteInAscoProceedings
Other,impactForTreatmentSelection
cancer,cyclin-dependentKinasesApprovedForTreatmentOfHormoneReceptor-positiveEpidermalGrowthFactorReceptorAdvancedBreastCancerInCombination
cancer,cyclin-dependentKinasesApprovedForTreatmentOfReceptor-positiveEpidermalGrowthFactorReceptorAdvancedBreastCancer
Other,perceived
Other,prognosticValueOfHubGenes
cancer,cyclin-dependentKinasesApprovedForTreatmentOfHormoneReceptor-positiveHumanGrowthFactorReceptor2-negativeBreastCancer
Other,care
Other,6SubtypesWithSignaturesWithDifferentPrognoses
Other,canDeliveredEffectivelyByTeamWithinPatientEducationAppointment
Other,numberOfSeromaAspirationsConsistOfNumber
Other,commonOralAgentForTreatmentOfPost-menopausalOsteoporosis
Other,higherEnhancement
Other,mightEffectForPatients
Other,timeToTreatmentFailureInCombinationAsSecond-line
Other,collected
Other,esccCellLines
Other,currentKnowledgeOnCircrnas
Other,treated
Other,manyAspectsOfTheirLife
Other,marrowMetastasisFromSolidTumors
Other,womenWithHer2-positiveBcsTreatedFrom2008To2017
Other,ultrastructure
Other,inPhageDisplayImmunotherapyPresentedByGeneticFusions
Other,aspectsOfPhenotypeIncludingCellProliferation
cancer,contextOfBreastCancer
Other,significance
Other,significantlyHigher
Other,patientSelection
cancer,cyclin-dependentKinasesApprovedForTreatmentOfReceptor-positiveEpidermalGrowthFactorReceptor2-negativeAdvancedBreastCancer
anticancer,anticancerActivities
Other,lungs
Other,higherExpressionOfLincrna-ror
Other,5YearsOfTamoxifenTherapyWith5Years
cancer,kinasesApprovedForTreatmentOfHormoneReceptor-positiveEpidermalGrowthFactorReceptor2-negativeBreastCancerInCombination
cancer,kinasesApprovedForTreatmentOfHormoneReceptor-positiveEpidermalGrowthFactorReceptor2-negativeAdvancedBreastCancer
Other,postmenopausalWomenWithDiseaseProgressionFollowingEndocrineTherapy
cancer,cyclin-dependentKinasesApprovedForTreatmentOfHormoneReceptor-positiveHumanGrowthFactorReceptor2-negativeAdvancedBreastCancer
cancer,growthPathwayInHrBreastCancer
Other,showInvasiveness
Other,presentlyLaboratory
cancer,kinasesApprovedForTreatmentOfHumanGrowthFactorReceptorAdvancedBreastCancerInCombination
Other,cases
Other,resultFromDiffuseAdenocarcinomaMetastasis
cancer,kinasesApprovedForTreatmentOfEpidermalGrowthFactorReceptorAdvancedBreastCancerInCombination
Other,1
Other,ET
Other,impactOfHeterogeneity
cancer,kinasesApprovedForTreatmentOfReceptor-positiveEpidermalGrowthFactorReceptorBreastCancerInCombination
Other,pivotalRole
Other,creationOfCases
Other,centralNervousSystemMetastasesAmongSevereMalignancies
Other,threeMetricsOfMortality
cancer,patientsWithBreastCancer
Other,sensitivityOfBcMad-mb-231Cells
cancer,kinasesApprovedForTreatmentOfReceptor-positiveHumanGrowthFactorReceptor2-negativeBreastCancerInCombination
Other,diffuseAdenocarcinomaMetastasisFromSite
Other,coactivatorsForErÎ±
Other,acid
Other,5YearsOfTamoxifen
Other,continuousCurves
Other,compared
perfusion,chemotherapyInjectionInTumorModel
Other,BCCT.core
Other,menopause
Other,available
Other,matchingPatternsSeen
Other,impactOfIntratumorHeterogeneityInDiagnostics
perfusion,patient-based4dBreastPhantomIncludingTime-varyingContrastEnhancementForSimulationOfDedicatedBreastCtPerfusionImaging
cancer,cyclin-dependentKinasesApprovedForTreatmentOfHumanGrowthFactorReceptorBreastCancer
Other,demonstratedByUpregulationOfE-cadherinExpression
Other,oncologyDivision
Other,utilizationOf3-o-p-coumaroyltormenticAcid
Other,assessed
cancer,kinasesApprovedForTreatmentOfReceptor-positiveEpidermalGrowthFactorReceptor2-negativeBreastCancer
Other,realistic4dBreastPhantomIncludingContrastEnhancementForSimulation
Other,peptidesDerivedAsVaccineDeliveryModalities
cancer,cyclin-dependentKinasesApprovedForTreatmentOfReceptor-positiveHumanGrowthFactorReceptor2-negativeBreastCancer
Other,expectedEnhancementOfTissues
cancer,subtypeOfBreastCancerWithPoorClinicalOutcome
Other,keyRole
cancer,cyclin-dependentKinasesApprovedForTreatmentOfHormoneReceptor-positiveHumanGrowthFactorReceptorAdvancedBreastCancerInCombination
Other,kinasesApprovedForTreatmentInCombinationWithFulvestrantInWomen
antioxidant,antioxidantScavengingAgainstHumanCellLines
Other,rise
imaging,canUsedDuringDevelopmentOfDynamicContrast-enhancedDedicatedBreastCtImagingForOptimization
cancer,estrogenReceptor-positive/humanEpidermalGrowthFactorReceptorBreastCancer
cancer,estrogenReceptor-positive/humanEpidermalGrowthFactorReceptor2-negativeBreastCancer
Other,transitionFromG0/g1-phaseToS-phase
Other,forOutcome63Months
Other,meningiomaRisk
Other,june2016
cancer,kinasesApprovedForTreatmentOfHormoneReceptor-positiveEpidermalGrowthFactorReceptorBreastCancerInCombination
Other,commonAgentForTreatment
Other,differentEnhancementDynamics
Other,generallyHigh
cancer,kinasesApprovedForTreatmentOfHormoneReceptor-positiveHumanGrowthFactorReceptorAdvancedBreastCancerInCombination
Other,bp-naÃ¯veOnes
Other,mayPotentialTherapeuticTargetInEscc
Other,endocrineTherapyChoice
Other,administered
cancer,breastCancerMigration
Other,breastCosmesis
Other,withDevelopmentOfHigh-throughputSequencingHaveDiscovered
Other,prediction
Other,howeverScarce
prognosis,unfavorablePrognosis
Other,stillScarce
Other,newModalities
Other,realistic4dDigitalBreastPhantomIncludingContrastEnhancement
cancer,significantReductionInBreastCancerGrowth
Other,resultFromAdenocarcinomaMetastasis
Other,15Fractions
irradiation,adjuvantPartialBreastIrradiation
Other,transitionFromG0/g1-phase
cancer,outcomeOfHr-positiveBreastCancerPatientsTreated
Other,inHybridization
Other,increaseInErÎ±ProteinLevels
Other,progression
Other,leadingCause
Other,distancesBetweenFeatures
Other,btBoost
Other,canDeliveredByTeamWithinPatientEducationAppointment
Other,56Years
Other,humanOrigin
Other,alsoConsidered
Other,inCox'sHazardsSurvivalModelAssociatedWithHazardRatioOf004
Other,twoGroupsIncluding196Patients
Other,monolayers
Other,bcMad-mb-231Cells
cancer,kinasesApprovedForTreatmentOfReceptor-positiveHumanGrowthFactorReceptorAdvancedBreastCancerInCombination
cancer,kinasesApprovedForTreatmentOfEpidermalGrowthFactorReceptor2-negativeAdvancedBreastCancerInCombination
Other,ionizationMassSpectrometry
Other,thereforeCrucial
multicatheter,multicatheterBrachytherapy
Other,yearsOfIntensiveResearch
cancer,cyclin-dependentKinasesApprovedForTreatmentOfHormoneReceptor-positiveHumanGrowthFactorReceptorBreastCancer
cancer,cyclin-dependentKinasesApprovedForTreatmentOfHumanGrowthFactorReceptorBreastCancerInCombination
Other,additiveManner
cancer,cyclin-dependentKinasesApprovedForTreatmentOfHormoneReceptor-positiveEpidermalGrowthFactorReceptor2-negativeAdvancedBreastCancerInCombination
Other,promise
Other,pi3k/akt/mtorSignalingPathway
Other,proportionalHazardsSurvivalModel
Other,canDeliveredEffectivelyByPractice-basedClinicalTeamWithinPatientEducationAppointment
Other,differentTypesOfBreastLesions
perfusion,realisticPatient-based4dDigitalBreastPhantomIncludingContrastEnhancementForSimulationOfDedicatedBreastCtPerfusionImaging
Other,timeToTreatmentFailureAsSecond-line
cancer,kinasesApprovedForTreatmentOfReceptor-positiveHumanGrowthFactorReceptorBreastCancer
Other,theirRelations
Other,lineSettings
Other,presentedByGeneticFusions
Other,phantom
Other,growth
Other,oralAgent
Other,continue
perfusion,patient-based4dDigitalBreastPhantomIncludingContrastEnhancementForSimulationOfDedicatedBreastCtPerfusionImaging
cancer,post-menopausalWomenWithBreastCancer
cancer,erCancer
Other,tumorStage
Other,mbcPatientsWithPriorExposureToAiTherapy
Other,canAlsoSimulatedForTumorModels
Other,ones
perfusion,4dDigitalBreastPhantomIncludingTime-varyingContrastEnhancementForSimulationOfBreastCtPerfusionImaging
Other,kinasesApproved
Other,combinatorialAnti-proliferativeEffects
Other,photographs
Other,4dBreastPhantomIncludingTime-varyingContrastEnhancement
Other,enrolled
Other,willRandomized
cancer,alsoConsideredAsNewCancerVaccineDeliveryStrategy
irradiation,scannedChemotherapy
Other,differentModels
Other,driversOfProliferationInHormoneReceptor
Other,6SubtypesWithDistinctMolecularSignaturesWithDifferentPrognoses
Other,withDevelopmentOfSequencingHaveDiscoveredInTumorousTissues
cancer,kinasesApprovedForTreatmentOfHormoneReceptor-positiveEpidermalGrowthFactorReceptor2-negativeBreastCancer
antioxidant,excellentAntioxidantAgainstCellLines
Other,supportiveCareAllowing
cancer,femaleBreastCancerPatientsUndergoing
Other,creationOfAbnormalCases
cancer,cyclin-dependentKinasesApprovedForTreatmentOfReceptor-positiveHumanGrowthFactorReceptorBreastCancer
Other,resistance
Other,breastReconstruction
Other,significantDifferencesBetweenViableTumor
Other,singleTamoxifen
Other,HER2-positive
cancer,cyclin-dependentKinasesApprovedForTreatmentOfEpidermalGrowthFactorReceptor2-negativeAdvancedBreastCancerInCombination
cancer,importantGrowthPathwayInHrBreastCancer
Other,distinctMolecularSignatures
Other,work
cancer,theirPotentialClinicalImplicationsOnBreastCancer
Other,theirPotentialClinicalImplications
Other,finallyCanSimulatedForTumorModels
Other,peptidesDerived
Other,controversial
Other,level1Doses
cancer,breastCancerMetastasisPrevention
Other,activity
cancer,mayKeyFactorInProgressionOfBreastCancer
Other,alsoPerformed
Other,cellLines
cancer,prognosisOfBreastCancerEspecially
Other,searchOfDataOnPalbociclibInPubmedInFdaWebsiteInAscoProceedings
Other,willAllocatedToOneOfThreeTreatmentArmsConsisting
Other,upregulation
Other,evenDismalCondition
Other,kinasesApprovedForTreatmentInCombinationWithFulvestrantInWomenWithDiseaseProgressionFollowingEndocrineTherapy
Other,managementChallenges
Other,response
perfusion,realistic4dDigitalBreastPhantomIncludingTime-varyingContrastEnhancementForSimulationOfBreastCtPerfusionImaging
cancer,kinasesApprovedForTreatmentOfHormoneReceptor-positiveEpidermalGrowthFactorReceptor2-negativeAdvancedBreastCancerInCombination
imaging,canUsedDuringDevelopmentOfDynamicDedicatedBreastCtImagingForOptimizationOfImageAcquisition
Other,pathways
Species,mice
Species,patients
Species,women
Species,mouse
Species,patient
Chemical,palbociclib
Chemical,Palbociclib
Chemical,fulvestrant
Chemical,alendronate
Chemical,Tamoxifen
Chemical,naringenin
Disease,tumors
Disease,neutropenia
Disease,death
Disease,skinToxicity
Disease,cancer
Disease,deadliestCancers
Disease,sexualDysfunctions
Disease,triple-negativeBreastCancer
Disease,boneLoss
Disease,TNBC
Disease,breastCancer
Disease,breastCancer
Gene,HR
Gene,CXCL1
Gene,mucin1
Gene,TDO2
Other,concentrations
Other,level1Group
Other,its
Other,itsSignaling
Other,macrophages
RNA-regulator,largeRna-regulator
Other,geneOntologyFunction
Other,Overexpression
Other,type
Other,second-leadingCause
prognosis,productivePrognosisDiscussions
Other,audioAnalysis
Other,mastectomies
Other,tamoxifenResistance
Other,196Patients
Other,This
Other,we
imaging,breastUltrasound
antioxidant,antioxidantActivity
Other,threeVisualRepresentations
Other,primaryOutcome
Other,514Women
Other,progression-freeSurvival
Other,time-enhancementCurves
Other,problems
Other,targets
Other,3dStaticPhantom
ESR1,plasmaEsr1MutationAssessment
Other,Data
Other,severalClinicalTrials
Other,furtherPros
Other,tissues
Other,historicalCohortStudy
Other,targetedAgents
Other,AO
Other,kinases
Other,camphorata
Other,invasiveness
Other,aldehydeDehydrogenase
Other,meningiomaRisks
Other,efficacy
Other,p
Other,cxcl1-basedTherapy
Other,candidates
Other,findings
Other,treatmentFailure
Other,clinicalTrials
Other,abundantChemokine
Other,purpose
Other,typical4d
Other,Agents
Other,circumstances
Other,survival
Other,clinicopathologicalParameters
Other,Agreement
Other,clinicalMeasurements
Other,theirPotential
irradiation,partialBreastIrradiation
perfusion,chemotherapyInjection
Other,brcaStatus
Other,Analysis
Other,multicenterControlledTrial
Other,symptoms
Other,G1
Other,theirAverageAge
Other,preoperativeClinicalMeasurements
Other,endocrineTherapy
Other,greatPromise
Other,therapeuticTargets
Other,dynamics
Other,repeatedPreparations
Other,post-menopausalWomen
Other,80
Other,ZJU-0725
Other,qpcrScreening
Other,evaluation
pallidus,pallidus
Other,impact
Other,mbcPatients
cancer,cd44CancerStemCellMarker
Other,significantReduction
Other,aromataseInhibitors
Other,679Percecnt
Other,ongoingResearch
Other,3dPhantom
Other,sources
Other,total
Other,using
Other,EgKI-1
Other,targetingBreastCscs
Other,bilateralSalpingo-oophorectomy
Other,inModel
Other,Selection
Other,Expression
Other,preparations
Other,We
Other,cellAuthenticationTesting
RNA-regulator,intergenicNoncodingRna-regulator
Other,extendedTherapy
Other,selectiveEstrogenReceptorDegraders
Other,336Patients
Other,theirTreatment-relatedCosmeticChanges
Other,cyclin-dependentKinases
Other,women'sGoals
Other,characteristics
Other,treatment
Other,cosmeticOutcomes
Other,tolerability
Other,combinationTherapy
Other,erÎ±PolyubiquitinationInhibition
Other,descriptiveInformation
Other,differentPatterns
Other,co-exposure
imaging,chemicalExchangeSaturationTransferMri
Other,Interleukin-1
Other,degree
Other,4Patients
Other,recentStudies
Other,mechanisms
RNA-regulator,largeIntergenicRna-regulator
Other,effects
Other,supportiveCare
Other,onePhotograph
Other,pi3kInhibitors
Other,treatmentRegimens
Other,ourData
RNA-regulator,noncodingRna-regulator
Other,childhood
Other,cosmeticOutcomes
Other,ieSeromaAspirations
Other,parameters
Other,treatableDisease
Other,methods
Other,diffuseAdenocarcinomaMetastasis
Other,examinations
Other,905Percecnt
Other,goal-setting
Other,significantTumorGrowthReduction
Other,estrogenReceptorDegraders
pallidus,orthosiphonPallidusExtract
Other,percecnt
Other,severalParameters
Other,cestSignals
Other,function
Other,proliferation
Other,women'sPersonalGoals
Other,benefits
Other,personalGoal-setting
Other,femalePatients
Other,2MutationCarriers
Other,tumor-associatedMacrophages
Other,mrnaExpression
Other,consecutivePatients
irradiation,adjuvantAcceleratedPartialBreastIrradiation
Other,sexualFunction
Other,results
Other,inMolecularMarkers
Other,mad-mb-231Cells
Other,rate
Other,cohortStudy
Other,recapitulating
Other,limitedInformation
Other,P
Other,canineTapewormEchinococcusGranulosus
Other,671Percecnt
Other,clinicalImplication
Other,theirImportance
Other,recombinantEgki-1
Other,4D
Other,acTreatment
Other,functionalAnnotation
Other,cohortStudy
Other,studyPopulation
Other,irMrnaExpressionLevels
Other,anonymousQuestionnaire
Other,recommendations
Other,mayPotentialTherapeuticTarget
Other,photograph
Other,itsPotentialPracticalApplications
Other,instruments
Other,other4Patients
Other,severalClinicopathologicalParameters
Other,latestAdvancements
Other,furtherInvestigation
Other,cellProliferation
Other,long-termIntervention
Other,correlation
irradiation,adjuvantBreastIrradiation
Other,analysis
compound,isolatedCompound
Other,bp-treatedPatients
Other,mastectomy
Other,nineteenFemalePatients
Other,seromaFormation
Other,arterialSources
Other,64-year-oldWoman
biomarkers,predictiveBiomarkers
Other,enhancedUnderstanding
Other,theirTumorigenicPotential
Other,CSCs
Other,upregulatedExpression
Other,multigeneAssays
Other,endocrineTherapy
Other,estrogenReceptorPositivePatients
cancer,breastCancerCells
Other,Results
Other,search
Other,806Percecnt
Other,Display
Other,subtype
Other,antrodiaCamphorata
Other,t-patParticipants
Other,visits
Other,silenceLincrna-ror
Other,outcome
Other,naringeninTreatmentGroup
Other,doses
Other,agents
Other,ERI
Other,salpingo-oophorectomy
Other,breastLesionModel
Other,cellMigration
Other,skinToxicities
Other,acuteSkinToxicities
Other,heterogeneity
Other,systems
Other,cancerStemCells
Other,Cox
Other,combinations
Other,differentSubtypes
Other,Prognosis
Other,egki-1Treatment
Other,virusTherapy
Other,interaction
Other,Meta-analysis
Other,sexualFunction
Other,treatmentSelection
cancer,breastCancerXenografts
Other,pathway
Other,mammography
Other,PROs
Other,data
irradiation,acceleratedBreastIrradiation
Other,brcaMutationalStatus
Other,bp-treatedWomen
cancer,basal/humanGrowthFactorReceptor2-positiveBreastCancer
Other,immediateVerbalMemoryIndex
Other,expression
Other,cellCycle
Other,History
Other,increase
Other,Knockdown
Other,otherPatients
Other,threeRepresentations
Other,phageConstructFormulation
cancer,basal/humanGrowthFactorReceptorBreastCancer
Other,oncolyticVirusTherapy
Other,intensiveImmunohistochemistryStudy
Other,understanding
Other,kyotoEncyclopedia
Other,boneMetastases
Other,role
Other,retrospectiveStudy
Other,AC
Other,averageTime
Other,maximum
Other,tdo2ProteinExpression
Other,assays
Other,immediateBreastReconstruction
Other,3-o-p-coumaroyltormenticAcid
Other,lowerOverallSurvival
Other,787ConsecutivePatients
Other,information
Other,ourReview
Other,adjuvantBreastRadiotherapy
Other,curves
Other,stratification
Other,theirCosmeticChanges
Other,lowRate
Other,ovTherapy
Other,contributing
Other,e-cadherinExpression
Other,femalePatients
Other,conclusionsPalbociclib
Other,Pearson
Other,hormone
Other,tenHubGenes
irradiation,decline
Other,lateRecurrences
Other,itsPotentialApplications
Other,measurements
Other,DEGs
Other,it
Other,The
Other,silencingLincrna-ror
Other,bisphosphonateTreatment
Other,anti-epithelial-to-mesenchymalTransitionProperties
Other,sameTime
Other,morePatients
Other,erÎ±PolyubiquitinationEstrogenReceptorDegraders
RNA-regulator,largeNoncodingRna-regulator
Other,mtorInhibitorEverolimus
Other,intervention
Other,anti-estrogenTherapy
Other,advancements
Other,evidence
Other,end
irradiation,chemotherapy
Other,erÎ±PolyubiquitinationSelectiveEstrogenReceptorDegraders
imaging,breastMri
Other,massiveCircrnas
Other,exponential
Other,Ã
perfusion,perfusion
Other,modality
Other,cosmeticOutcome
Other,study
Other,furtherEndocrineTherapyChoice
Other,overcoming
Other,irSignalling
Other,research
Other,aim
Other,postmenopausalWomen
Other,highRisk
Other,estrogenReceptorPatients
Other,tam-secretedCytokines
Other,recurrences
RNA-regulator,RNA-regulator
Other,intraclassCorrelationCoefficient
Other,fifty-threePatients
Other,highCxcl1Expression
Other,invasionAbility
cancer,basal/humanEpidermalGrowthFactorReceptorBreastCancer
Other,potentActivity
Other,combination
Other,immunohistochemistryStudy
Other,potentialApplications
Other,geo2rTool
Other,treatmentImprovements
Other,care
Other,oralBisphosphonateTreatment
Other,suspiciousPrimaryLesion
Other,morphologicalChanges
Other,multipleCytokines
Other,objective
Other,inhibition
ESR1,plasmaEsr1MutationCarriers
Other,variousMethods
Other,pik3caMutations
Other,cytokines
Other,activity-guidedFractionation
Other,lincrna-rorExpression
Other,primaryDysfunctions
Other,diseaseNature
Other,had
Other,predictiveRole
Other,patientSelection
Other,recurrenceRisk
anticancer,anticancerActivities
Other,proposedDigitalPhantom
cancer,breastCancerPatients
Other,samples
Other,Inhibition
Other,mayKeyFactor
Other,511Percecnt
Other,primaryObjective
Other,21Skin-sparingMastectomies
Other,extranuclearActivity
Other,64-year-oldWoman'sHeadache
Other,deaths
irradiation,acceleratedPartialBreastIrradiation
Other,polyubiquitination
Other,4dPhantom
Other,majority
Other,3Patients
Other,cases
Other,maximumResponse
prognosis,prognosisDiscussions
Other,1
Other,bcTissues
Other,patterns
RNA-regulator,intergenicRna-regulator
Other,use
pallidus,aqueousOrthosiphonPallidusExtract
Other,itsLigand
Other,theirAge
Other,meanIncrease
cancer,basal/humanEpidermalGrowthFactorReceptor2-positiveBreastCancer
Other,publishedFemales
Other,acid
cancer,femaleBreastCancerPatients
Other,letrozoleTherapy
Other,investigated
Other,G2
Other,dose
Other,medianTime
Other,woman'sHeadache
Other,primarySexualDysfunctions
Other,theDelayed
Other,heterogeneousTumors
Other,mtrValues
Other,threeNovelBasal/her2
Other,sustainedResponse
Other,t-patClinicians
Other,possibility
Other,personalizedTherapy
Other,VMAT-SIB
Other,threeBasal/her2
Other,therapies
RNA-regulator,largeIntergenicNoncodingRna-regulator
Other,events
Other,activities
Other,trials
Other,typical4dPhantom
Other,chromatographicPreparations
Other,noncytotoxicConcentrations
Other,cxcl1Expression
Other,formation
Other,selectionTools
Other,exclusionCriteria
Other,studies
Other,patientSelf-reports
Other,TAMs/CXCL1
Other,severalAspects
Other,probability
Other,e3-ubiquitinLigases
Other,cxcl1Silencing
Other,growthHormoneTreatment
Other,dfsRate
Other,multipleTam-secretedCytokines
Other,tdo2Overexpression
Other,combinedTreatment
Other,outcomes
Other,protein-proteinInteraction
cancer,cancerDiagnosis
Other,Comparison
Other,50Patients
Other,6Subtypes
Other,hypofractionatedVmat-sib
Other,association
Other,seriousDamage
Other,estrogenReceptorAlpha
Other,OBCS
Other,predicting
Other,Two-thirds
Other,time
Other,peptide
Other,questionnaire
Other,co-treatment
Other,tdo2Function
Other,anthracycline-basedAdjuvantTherapies
Other,newModalities
Other,rnaInterference
biomarkers,biomarkers
Other,japanesePatients
irradiation,adjuvantPartialBreastIrradiation
Other,suspiciousLesion
Other,electronBoost
Other,pi3k/akt/mtorPathway
Other,correspondingTime-enhancementCurves
Other,subgroupAnalyses
Other,preciseStratification
Other,amedDatabases
Other,evaluate
Other,enrichmentAnalysis
Other,interactions
Other,iClinicalStudy
Other,coefficient
Other,btBoost
Other,percentCytotoxicity
Other,receptorActivator
Other,damage
Other,severalTrials
Other,quilting
Other,correlationCoefficient
Other,preoperativeMeasurements
Other,mean
Other,It
Other,insulinResistance
Other,periodicExaminations
Other,risk-reducingMastectomy
Other,erÎ±Polyubiquitination
Other,repeatedChromatographicPreparations
Other,fractionation
Other,quality
Other,risk
Other,lateRecurrenceRisk
Other,clinicians
Other,model
Other,correspondingCurves
Other,higherExpression
Other,cdk4/6InhibitorPalbociclib
Other,digitalPhantom
Other,4dArray
Other,phantom
Other,implication
Other,intraoperativeFindings
Other,near-tetraploidKaryotype
Other,growth
Other,backbone
Other,multivariableCox
Other,annotation
Other,ourScopingReview
Other,therapy
Other,optimalPatientSelection
Other,chemokine
compound,compound
Other,earlyDynamics
Other,diagnosis
Other,inhibitors
Other,support
Other,aspects
Other,tnbcPatients
Other,S961
Other,intratumorHeterogeneity
Other,cells
Other,photographs
Other,geneSet
irradiation,breastIrradiation
pallidus,orthosiphonPallidus
Other,proposedPhantom
Other,616Percecnt
ESR1,plasmaEsr1Mutations
Other,epithelial-mesenchymalTransition
Other,oncolyticViruses
Other,nature
Other,irAntagonist
Other,showing
Other,mostPatients
Other,circRNAs
Other,effect
Other,distinctMolecularSignatures
Other,sensitivity
Other,tumorModels
Other,estrogenReceptor
Other,work
irradiation,adjuvantAcceleratedBreastIrradiation
Other,theirAssociation
Other,mainProblems
Other,activity
Other,cellLines
Other,pooledAnalysis
Other,intratumorHeterogeneity
Other,changes
Other,importantGrowthPathway
Other,dysfunctions
Other,5Years
Other,managementChallenges
Other,response
Other,extendedEndocrineTherapy
Species,participants
Species,Patients
Species,Women
Species,viruses